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ABSTRACT 
 
 
Development of Osteoinductive Tissue Engineering  
Scaffolds with a Bioreactor 
 
by 
 
Richard A. Thibault 
 
The conventional treatments for craniofacial bone defects currently are unsatisfactory 
due to several drawbacks.  Replacement of lost bone by autografts typically causes 
donor site morbidity while allografts, xenografts, and demineralized bone matrix have a 
chance of disease transmission.  Current synthetic implants placed within the defect site 
generally lack osteogenicity and biodegradability.   
 
There are several methods of generating an extracellular matrix (ECM) and synthetic 
material hybrid construct.  These include coating a scaffold with collagen and calcium 
phosphate, incorporating acellular biological tissue within scaffolding material, and using 
cells to generate an ECM coating on the scaffold.  The research performed in this thesis 
developed and characterized mesenchymal stem cell (MSC)-generated ECM poly(ε-
caprolactone) constructs (PCL/ECM) for the replacement of bone. 
 
The osteogenic potential of the PCL/ECM constructs was explored by culturing MSCs or 
whole marrow cells combined with MSCs onto the construct with or without the 
osteogenic differentiation supplement, dexamethasone.  It was established that the 
osteogenic differentiation of MSCs seeded onto ECM-containing constructs was 
maintained even in the absence of dexamethasone and that the co-culture of MSCs and 
whole bone marrow cells without dexamethasone and ECM enhances the proliferation 
of a cell population (or populations) present in the whole bone marrow. 
 
The osteogenicity of the constructs encouraged the characterization of the protein and 
mineral composition of the ECM coating on the PCL/ECM constructs.  Characterization 
revealed that at short culture durations the MSCs used to generate the ECM deposited 
cellular adhesion proteins that are a prerequisite protein network for further bone 
formation.  At the later culture durations, it was determined that the ECM was composed 
of collagen 1, hydroxyapatite, matrix remodeling proteins, and regulatory proteins. 
 
The prior studies on the PCL/ECM constructs persuaded exploration of the effect of 
devitalization and demineralization processes on the retention of the ECM components 
within and the osteogenicity of the PCL/ECM constructs.  Analysis demonstrated that 
the freeze-thaw technique is a milder method of devitalization of cell-generated ECM 
constructs as compared to other methods.  In addition, it was elucidated that void 
spaces in the surface of the constructs were important for allowing access of MSCs into 
the interior of the constructs. 
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CHAPTER 1 
 
THESIS OVERVIEW 
 
Reconstructive surgeons face a significant challenge when repairing craniofacial 
bony defects caused by traumatic injury or tumor resection.  Currently, 
autogeneic bone grafts from the tibia, ribs, and iliac crest are the current gold 
standard graft material for bone defect repair in clinical settings.  However, 
treatments of these defects are may also be addressed by using synthetic graft 
materials such as ceramics and metals or allogeneic and xenogeneic tissues.  
There are inherent drawbacks to using each of these materials, with the main 
concerns being necrosis at the donor site for autogeneic tissues, the lack of 
degradation and osteointegration for many synthetic materials, and the potential 
for disease transmission in the case of allogeneic and xenogeneic tissues.  To 
address these pitfalls, tissue engineering seeks to develop an osteogenic 
construct that can reduce or replace the need for synthetic, autogeneic, 
allogeneic, and xenogeneic graft materials.   
 
The goal of the research presented within this thesis was to develop a 
biodegradable osteogenic extracellular matrix (ECM) and polymer construct for 
bone regeneration and identify the components within the ECM that encourage 
the osteogenic differentiation of mesenchymal stem cells (MSC).  Osteogenic 
differentiation of MSCs in vivo is dependent on ECM composition and signaling 
molecules as well as the mechanical forces that the cells experience. Thus, 
MSCs were cultured on electrospun poly(ε-caprolactone) (PCL) and exposed to 
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shear stress in the form of fluid flow and to an osteogenic differentiation 
supplement, dexamethasone to generate an osteogenic ECM coating on a PCL 
scaffold (PCL/ECM).  In order to elucidate the properties of this PCL/ECM 
construct, the following specific aims were proposed and investigated: 
1. Evaluate the osteogenicity of a statically generated PCL/ECM construct by 
culturing MSCs or MSCs and whole marrow cells onto the constructs 
under static conditions with or without the osteogenic differentiation 
supplement, dexamethasone 
 
2. Determine the temporal change in protein and mineral composition of 
PCL/ECM constructs generated within a flow perfusion bioreactor 
 
3. Determine the effect of various devitalization and demineralization 
processes on the ECM composition and osteogenicity of the treated 
PCL/ECM constructs 
 
This thesis starts with a review on the various methods of creating a hybrid ECM 
and scaffold construct for bone tissue engineering, which includes scaffolds 
coated with collagen and calcium phosphate, scaffolds incorporating 
decellularized biological tissue, and scaffolds with a cell-generated ECM coating.  
In Chapter 3, MSCs or MSCs and whole marrow cells were seeded onto the 
PCL/ECM constructs and cultured with or without dexamethasone to explore the 
osteogenicity of the constructs.  This study validated the osteogenicity of the 
PCL/ECM constructs and encouraged further research into the PCL/ECM 
constructs.  Chapter 4 investigates the composition of the PCL/ECM constructs 
to determine what components are important to the osteogenicity of the 
constructs.  Temporal differences in the protein and mineral composition of the 
PCL/ECM construct was observed and warranted additional investigation into the 
compositional changes in the MSC-generated ECM due to construct processing.  
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Chapter 5 elucidates the effect of the devitalization and demineralization 
processing on the ECM composition and osteogenicity of the PCL/ECM 
constructs.  This study demonstrated that processing causes visible void spaces 
in the outer ECM coating of the PCL/ECM constructs allowing access to the 
interior.  Lastly, the conclusions of this thesis and future directions of exploration 
into PCL/ECM constructs are presented in Chapter 6. 
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CHAPTER 2 
 
Scaffold/Extracellular Matrix Hybrid Constructs for Bone Tissue 
Engineering 
 
Abstract 
The limited natural ability of the body to fully repair large bone defects often 
necessitates the implantation of a replacement material to promote healing.  
While the current clinical strategies to address such bone defects generally carry 
associated limitations, bone tissue engineering approaches seek to minimize any 
adverse effects and facilitate complete regeneration of the lost tissue.  Of 
particular interest are hybrid constructs that incorporate multiple components 
found within native bone matrix to enhance the osteogenicity of biocompatible 
materials, which might otherwise be non-osteogenic.  This review will focus on 
such hybrid constructs that incorporate multiple components from native bone 
matrix for bone tissue engineering and will highlight the synthesis and 
characterization of the hybrid constructs, cellular attachment and proliferation 
within the constructs, in vitro osteogenicity of the constructs, and the biological 
response to in vivo implantation of the constructs at ectopic and orthotopic sites. 
 
 
 
 
 
 
 
 
 
 
 
__________________________ 
* This manuscript was prepared as presented for submission to Advanced Healthcare Materials 
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2.1 Introduction 
Reconstructive surgeons often face significant challenges when repairing 
craniofacial bony defects arising from traumatic injury and tumor resection 
among other causes.  Currently, these defects are addressed clinically by using 
synthetic graft materials such as ceramics, polymers, and metals; autologous 
bone tissue; or allogeneic and xenogeneic demineralized bone matrix.1-4  
However, there are various inherent drawbacks associated with the use of these 
including a lack of biodegradability for most metals and for some ceramics, 
limited supply and donor site morbidity with autologous bone tissue, and the 
potential for disease transmission with allogeneic and xenogeneic tissue.3,5,6 
 
Tissue engineers seek to overcome these drawbacks by developing osteogenic 
materials that support the capacity of the body to regenerate bone and integrate 
with the surrounding bone tissue.  Prior approaches have focused on mimicking 
isolated components of native bone, such as the nanoscale extracellular matrix 
(ECM) architecture by using nanofibrous materials; the bioactive moieties by 
coating surfaces with cell-adhesive peptide sequences; the inorganic matrix 
elements by incorporating hydroxyapatite (HAp); and the signaling molecules by 
releasing growth factors from the materials.7-10  However, natural bone ECM is a 
composite material consisting of fibrous collagen, hydroxyapatite, proteoglycans, 
and growth factors.11  Recent approaches have evolved to generate 
scaffold/extracellular matrix hybrid constructs integrating the multiple 
components found in native bone matrix with synthetic biomaterials.  These 
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approaches typically include the use of porous scaffolds or polymeric carriers 
combined with various ECM components.  The synthesis and characterization, 
cellular attachment and proliferation, in vitro osteogenicity, and the biological 
response to in vivo implantation at ectopic and orthotopic sites of hybrid 
constructs incorporating multiple components of native bone matrix will be 
discussed in this review. 
 
2.2 Synthesis of Scaffold/ECM Hybrid Constructs 
Natural bone consists of collagen, HAp, and noncollagenous proteins such as 
proteoglycans, matrix metalloproteinases, and growth factors.11  The collagen 
present within bone is organized into fibers approximately 300 nm in length and 
1.5 nm in diameter.11,12  The fibers are mineralized with biological HAp, a 
calcium-deficient apatite with carbonate ion substitutions.  The plate-like HAp 
crystals grow preferentially along the collagen fibers and have very small 
crystallite sizes with a lower crystallinity than synthetic HAp.12  They are 
nucleated in the 40 nm gaps present between the collagen fibers and initiated by 
trace proteins bound to the collagenous ECM.  In addition to initiating HAp 
crystals, trace proteins are important for binding growth factors, remodeling the 
ECM, promoting angiogenesis, and inducing new bone formation.11 
 
There are many approaches for generating hybrid constructs for bone tissue 
engineering that can incorporate the key aspects of the composition of bone 
(Table 2.1).  One method includes coating a polymeric scaffold of micro- or 
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nano-scaled architecture with collagen and calcium phosphate.13,14  This type of 
construct is beneficial because of its simplicity and resemblance to bone ECM.  
The coating of both collagen and calcium phosphate may provide stem cells 
cultured within the construct an environment that encourages osteogenic 
differentiation and bone-like ECM deposition. On the other hand, such constructs 
may lack the complex organization and composition needed to provide cells with 
the biological cues to form bone.  The fibrillar structure of collagen or the 
inclusion of growth factors may be necessary to form bone correctly.  Another 
approach is to incorporate components of decellularized tissues within a 
polymeric carrier or scaffolding material.15,16 The use of decellularized tissue may 
allow for the inclusion of many of the proteins and minerals found in the biological 
tissue.  These decellularized tissues also retain much of their original structure 
and may provide cells with the correct template for tissue regeneration.  
Nevertheless, some devitalization processes may irreversibly damage the 
proteases and growth factors found in the native tissue, rendering them inactive.  
In addition, this approach requires donor tissue, although at lower amounts with 
respect to autologous, allogeneic, and xenogeneic bone grafts.  The same 
disadvantages observed with these grafts are also found in hybrid constructs 
incorporating biological tissues.  The last method covered in this review is the 
creation of a cell-generated ECM coating on the surfaces of the scaffold that 
mimics the composition of native bone.17,18  Osteoblasts or osteogenically 
differentiated stem cells are typically used to generate the ECM coating.  This 
cell-generated ECM coating may potentially have all the components that can 
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regulate the composition and organization of the ECM similar to that of native 
bone.  However, disadvantages to this method are that the biological 
components of this construct are difficult to characterize and the optimal cell 
culture time to generate an osteogenic ECM coating must be elucidated.  In 
addition, it is difficult to provide the cells with the correct distribution and 
environment to evenly deposit the osteogenic ECM coating throughout the 
scaffold. 
 
2.2.1 Polymeric Constructs Incorporating Collagen and Calcium Phosphate 
These hybrid constructs seek to mimic bone ECM by combining porous 
polymeric scaffolds that have nano- and micro-sized features with collagen and 
calcium phosphate (Figure 2.1).  Also under consideration are hybrid constructs 
incorporating gelatin instead of collagen.  Although, gelatin is a hydrolyzed form 
of collagen, it has a similar composition, allows for cell adhesion, and is 
biodegradable in vivo.19-21 
 
Three major methods of construct synthesis have been reported in the literature. 
The first method involves a polymer scaffold coated initially with collagen and 
subsequently with hydroxyapatite.  The second method uses a combination of 
polymer, collagen, and calcium phosphate in suspension to generate a hybrid 
construct after the removal of the solvent.  The third method combines the two 
prior methods by incorporating either the collagen or the calcium phosphate into 
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the polymer solution, removing the solvent, and then coating the surface of the 
composite scaffold with the other component.   
 
In the first method, the generation of the synthetic portions of several hybrid 
constructs was accomplished in several ways, including electrospinning, 3D 
printing, and freeze-drying of polymer solutions.13,14,22  Electrospinning creates a 
non-woven fiber mesh mat with controllable fiber diameter, porosity, and 
thickness.23  With 3D printing, it is possible to generate a scaffold with a pre-
determined macrostructure and microstructure.24  Freeze-drying of polymer 
solutions can create a porous sponge with a controlled pore structure.25  Each of 
these methods is capable of creating a highly porous scaffold that allows for the 
penetration of the coating solutions throughout the scaffold. 
 
Following fabrication, the scaffold may be submerged within a collagen or gelatin 
solution and subsequently in simulated body fluid (SBF) solution to generate a 
coating of collagen or gelatin and HAp on the polymer surface.  A layer-by-layer 
method may be used to control the thickness of the coating.26  As an example, Li 
et al. coated a poly(ε-caprolactone) (PCL)  scaffold several times, first with 
gelatin followed by a number of layers of poly(styrene sulfonate) and finally with 
gelatin.13  The amount of HAp present on the scaffold may also be controlled by 
varying the incubation time within the SBF solution.  SBF has nearly the same 
ionic concentration as human plasma but is highly supersaturated with respect to 
apatite.27  As a result, SBF forms bone-like HAp crystals on bioactive surfaces 
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such as collagen or gelatin.27  However, SBF with the same concentration as 
human plasma (1X SBF) may take more than 16 days to fully coat a surface with 
HAp.28  Therefore, in order to decrease the mineralization time, SBF with up to 
10 times the concentration of ions found in 1X SBF may be used.  To further 
decrease the construct preparation time, it is possible to soak scaffolds in a 
combined collagen and SBF solution.  Yun et al. used this combined method and 
were able to remove a fully coated construct after 24 hours.14 
 
The second method uses electrospinning, lyophilization, or vacuum evaporation 
to remove the solvent from a polymer, collagen, and calcium phosphate 
suspension.  As an example, Zhang et al. dispersed chitosan, bovine collagen, 
and HAp nanoparticles in dimethyl sulfoxide and acetic acid and created a 
nanofibrous scaffold by electrospinning.29  Lyophilization was used to generate 
sponges from a suspension of micro-sized HAp with chitosan and gelatin or a 
suspension of alginate, porcine gelatin, and β-tricalcium phosphate (TCP).30,31  In 
another method, a porous sponge was generated via lyophilization using ice 
microparticles as a porogen.32  Specifically, Li et al. created ice microparticles 
from a solution of bovine collagen with dispersed 500 nm sized HAp particles 
frozen in liquid nitrogen.  The ice microparticles were combined with poly(L-lactic 
acid) (PLLA) dissolved in dioxane at -5oC, kept in liquid nitrogen for 12 hours, 
and lyophilized to remove the solvents.  Li et al. also created porous scaffolds 
through vacuum evaporation.  They combined HAp nanoparticles with bovine 
collagen and paraffin microspheres in water and malonic acid, allowed the 
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mixture to air dry, and followed by cross-linking of the collagen using 
formaldehyde.  Subsequently, poly(lactic-co-glycolic acid) (PLGA) dissolved in 
pyridine was drop-cast into the interspace between the paraffin microspheres.  
The pyridine solvent was allowed to evaporate under low vacuum and then the 
paraffin microspheres were dissolved with cyclohexane, resulting in composite 
scaffolds.33 
 
In the third method, constructs are typically fabricated by electrospinning or 3D 
printing of a polymer and either collagen or calcium phosphate solution followed 
by the coating of the scaffold with calcium phosphate or collagen, respectively.  A 
nanofibrous polymer scaffold was generated by electrospinning a combination of 
PLLA, poly(benzyl-L-glutamate) (PBLG), and collagen dissolved in 1,1,1,3,3,3-
hexafluoro-2-propanol (HFIP).34  The nanofibrous scaffold was then coated with 
nano-sized crystals of HAp using 3 cycles of dipping in calcium chloride followed 
by dipping in sodium pyrophosphate.  Another hybrid construct was generated by 
electrospinning PLGA combined with amorphous calcium phosphate and 
collagen I.35  The collagen within the scaffolds was cross-linked with 
glutaraldehyde and then incubated in SBF to create a HAp coating.  3D printing 
was used to generate a PLGA and TCP composite thumb-shaped scaffold, with 
multiple 1 mm by 1 mm channels present throughout.36  The scaffold was 
subsequently coated with a collagen-based hydrogel containing human 
mesenchymal stem cells (MSCs). 
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2.2.2 Biological Tissue ECM-based Construct  
Biological tissue ECM-based constructs generally consist of a polymeric carrier 
material and acellular biological tissue (Figure 2.2).  Most of these hybrid 
constructs incorporate demineralized bone matrix (DBM) because of the 
osteogenic factors known to be present within DBM.16,37,38  However, some 
constructs use acellular bone matrix (ABM) or acellular urinary bladder 
submucosa (UBS).15,39 
 
DBM is an osteoinductive material that is generated by decellularizing and 
demineralizing cortical bone.40  A typical method of generating powdered DBM 
involves first cleaning of cortical bone to remove any remaining soft tissue 
followed by rinsing with a saline solution.40,41  The bone is subsequently cut into 
small fragments and defatted and dehydrated using a 1:1 chloroform-methanol 
solution.  The resulting fragments are frozen and pulverized into particles of sizes 
in the sub-millimeter range using a mill or mortar and pestle.  The particles are 
then demineralized using hydrochloric acid ranging from 0.1 – 0.6 N at 4oC and 
sterilized using ethylene oxide.41  ABM is generated in a similar manner as DBM, 
but there is no demineralization step.  Instead it is generated by sterilizing the 
bone particulates with ethylene oxide immediately following the pulverization 
step.39   
 
UBS is generated from the submucosal layer of the smooth muscle layer of the 
bladder.  One method of creating UBS is by mechanical delamination of the 
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submucosa from the smooth muscle followed by a treatment with dilute peracetic 
acid and deionized water to render the tissue acellular.15  The acellular tissue is 
subsequently lyophilized and pulverized using a mortar and pestle to create a 
powder of particulates in the range of 100 to 500 µm.15 
 
Each of these decellularized tissues provides many of the native components of 
the tissue.  UBS is composed mainly of collagen, but also retains fibroblast 
growth factor (FGF) and vascular endothelial growth factor (VEGF).42  ABM 
contains both the organic matrix and the mineral components of bone whereas 
DBM only retains the organic matrix.  However, it has been shown that 
demineralization of bone matrix increases access to the bone morphogenic 
proteins (BMP) bound to the organic matrix.43  The presence of BMPs have been 
shown to induce bone formation at an ectopic site.44  Thus, DBM should provide 
any seeded cells with access to BMPs.  Nevertheless, it is possible to 
excessively demineralize the tissue and deplete the BMPs from DBM.45  In 
addition, it has been shown that particulate size can affect the osteogenicity of 
DBM.46-48 
 
The formed particulates from different tissues are combined with either a liquid 
polymeric carrier that later solidifies to form a gel or combined with a polymer to 
form a film.  In the liquid polymeric carrier case, there are several types of 
polymers used and different methods of solidification employed.  For example, 
poly(ethylene glycol)-PCL-poly(ethylene glycol) (PEG-PCL-PEG)  co-polymer 
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was dissolved in water at 60oC, mixed with ABM, and cooled to form a composite 
gel.39  As another example, Kurkalli et al. combined rat DBM with Pluronic F-127, 
a reverse thermo-responsive polymer, and placed the solution in vivo to gel.38  
Reverse thermo-responsive polymers display low viscosity at room temperature, 
but form a gel at body temperature.49  In another study, porcine UBS and a 
sucrose polymer were combined with PLGA in solution, polymerized, and the 
sucrose polymer was dissolved away to form a porous structure.15 
 
In order to generate a film, a polymer and the acellular tissue particulates are 
combined and placed at the bottom of a well to generate a 2D surface that is a 
composite of the two materials.  Thomas et al. combined DBM particles with 
PLLA beads ranging from 0.52 mm to 1.91 mm in size at varying ratios to 
generate a 2D substrate.16  A film was generated by combining human ABM or 
human DBM with PLGA in chloroform.  The suspension was then cast as a thin 
layer in a petri dish and subsequently dried under air flow for 24 hours to create a 
composite thin film.37 
 
2.2.3 Cell-generated ECM-based Construct 
Cell-generated ECM-based constructs are generated by culturing stem cells, 
osteoblasts, or pre-osteoblastic cells on porous scaffolds.  The goal of this 
approach is to create a cell-generated ECM coating on the surfaces of the 
scaffold that mimics the composition of native bone (Figure 2.3). The cell culture 
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to generate the ECM has been performed under static conditions, flow 
conditions, electromagnetic stimulation, or dynamic strain. 
 
Static culture has been used to generate ECM coatings on scaffolds because of 
the ease of culture.  This method of culture works well for small scaffolds, where 
diffusional limitations of nutrients are less significant.50  The varieties of scaffolds 
that have been used in static culture include mineral pellets, porous polymer 
scaffolds, gelatin cryogels, and fiber mesh scaffolds ranging in thicknesses from 
0.8 mm to 5 mm.17,18,51-57  Osteoblast-like cell lines such as SaOS-2 cells, bone 
marrow stromal cells (BMSCs) from human and rat sources, and primary rat 
osteoblasts have been cultured on these scaffolds from a minimum of 16 days up 
to 6 weeks to generate the bone mimetic ECM. 
 
However, in large constructs, portions of the scaffold may encounter a lack in 
nutrients due to diffusional limitations, causing cells present in these areas to 
become less active.58  Bioreactor culture addresses the diffusional limitations by 
enhancing the mass transfer of nutrients and oxygen and the removal of 
metabolic waste products using fluid flow around or through the scaffold.58  In 
addition, fluid flow through the pores of constructs stimulates seeded cells in the 
form of shear stress, which has been shown to enhance osteogenic 
differentiation of stem and progenitor cells.59,60   
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Bioreactors involving flow culture conditions include a flow perfusion bioreactor, a 
rotational oxygen-permeable bioreactor, and a spinner flask bioreactor.  A flow 
perfusion bioreactor consists of a pump that perfuses constructs with media 
through a confined fluid path at a controlled flow rate.61,62  A variety of porous 
scaffold types have been placed within a flow perfusion bioreactor including foam 
and fiber mesh scaffolds.63-77  The cells cultured under flow perfusion conditions 
are similar to those cultured under static conditions and include SaOS-2 cells and 
BMSCs from human, rat, and goat sources and have been cultured from 15 days 
up to 40 days.  A rotational oxygen-permeable bioreactor consists of a rotating 
apparatus and a chamber which allows for gas exchange.78  Cell seeded 
constructs and media are placed within the chamber and rotated at a controllable 
rate, which causes the constructs to be continuously in free fall and thus 
subjected to constant fluid flow.58  Electrospun polymer fiber mesh scaffolds and 
polymer foam scaffolds have been cultured with rat BMSCs, rabbit amniotic 
MSCs, and porcine bone marrow progenitor cells using the rotational oxygen-
permeable bioreactor for durations ranging from 10 days to 34 weeks.79-82  The 
spinner flask bioreactor generates fluid flow by suspending constructs within a 
media reservoir and placing a stir bar at the bottom to stir the media at a 
controlled rate.83  A cell-generated ECM construct was created from silk fibroin 
scaffolds seeded with human BMSCs and cultured within a spinner flask that was 
stirred for 5 weeks.84 
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Analogous to shear stress, pulsed electromagnetic fields (PEMF) have been 
shown to stimulate osteogenic differentiation of stem cells and ECM 
mineralization.85,86  Additionally, dynamic loading has been shown to enhance 
matrix production and osteogenic differentiation.87,88  Both PEMF and dynamic 
loading have been used to generate an ECM coating on constructs without the 
addition of any osteogenic cell culture supplements.88-94  Polymer foams, gelatin 
cryogels, and titanium disks were used as scaffolds and cultured with such cells 
as the SaOS-2 cell line and human BMSCs.89-93  These cell-seeded constructs 
were statically cultured for 22 days or 6 weeks in the presence of an 
electromagnetic field and, in some cases, with additional ultrasonic stimulation.  
Investigators have also cultured polymer foam scaffolds with cells such as 
human MSCs and an osteoblastic cell line, MLO-A5, under 5% strain for 19 or 20 
days to enhance ECM production.88,94   
 
Also of note, several of the cell-generated ECM-based constructs were 
decellularized prior to analysis.  Most hybrid constructs underwent 3 cycles of 
freezing in liquid nitrogen and thawing in 37oC water followed by ultrasonication 
for 10 minutes.18,51,64,73,74,76  An alternate method of decellularization was 
accomplished by treating the constructs with 0.5% Triton X-100 and 20 mM 
ammonium hydroxide for 3 minutes at 37oC.57 
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2.2.4 Compositional and Physical Characterization of Hybrid Constructs 
While the method of synthesis for these various hybrid constructs drastically 
differs, the manner of characterization is quite similar.  Construct characterization 
has been approached using i) visualization of the distribution of cells, proteins, 
and minerals through the construct, ii) analysis of the protein and mineral 
composition, and iii) determination of physical characteristics. 
 
Scanning electron microscopy (SEM) allows for the visualization of micro- and 
nano-scaled features on the surface of the construct.  However, SEM does not 
allow for ready observation of the distribution or identification of the cellular, 
protein, and mineral components within the interior of hybrid constructs.  A 
combination of fluorescent staining and confocal microscopy has been used to 
demonstrate the distribution of cells throughout the construct.52,66  For further 
characterization of the biological factor distribution within the construct, several 
histological stains have been used, including methylene blue and hematoxylin & 
eosin for cells, alcian blue and Safranin O for proteins and glycosaminoglycans 
(GAGs), and alizarin red and von Kossa for minerals, while 
immunohistochemistry has been used to visualize the distribution of specific 
biological components.17,30,82,84 
 
In order to determine more precisely the composition of the hybrid constructs, the 
amount of proteins and GAGs have been determined using colorimetric assays 
and their identification has been established using  enzyme-linked 
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immunosorbent assay (ELISA), western blotting, and mass spectrometry.  
Typically, to determine the amount of proteins and GAGs in the construct, a 
detergent or chaotropic solution has been used to solubilize the proteins.17,55,92  
Once the proteins are in solution, colorimetric assays such as the bicinchoninic 
acid (BCA) assay, coomassie blue assay, 1,9-dimethylmethylene blue (DMMB) 
assay, and chloramine T assay have been used to determine protein and GAG 
amounts.14,57,92  Precise identification of the proteins and GAGs present within 
the protein solution can be performed via ELISA and western blotting using 
antibodies.95,96  Another method for precise identification of proteins in the 
solution combines a liquid chromatography column along with a tandem mass 
spectrometer (LC-MS/MS) and a protein database search engine.97  The protein 
solution first undergoes trypsinization and is then run through the liquid 
chromatography column, followed by injection into a tandem mass spectrometer.  
The resulting spectrum is analyzed by a protein database search engine and 
matched to specific proteins.97  If known amounts of the specific protein are 
analyzed in a similar manner, a standard curve can be created from the LC-
MS/MS spectra and the amount of the specific protein can be calculated.98   
 
However, each of these methods has a threshold necessary to correctly identify 
and determine the amount of a protein and a GAG.  The chloramine T, DMMB, 
and BCA assays are typically able to detect molecular concentrations in the 
micromolar ranges, although submicromolar ranges have been reached using 
various modifications.99-101  The coomassie blue staining typically can only detect 
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greater than 10 ng of protein, but has been recently improved to detect greater 
than 2 ng of protein.102  Meanwhile, the techniques that use antibodies allow for 
the detection of proteins at much lower levels.  Conventional ELISA has a 
detection limit in the picomolar range, but using a modified technique, detection 
in the subfemtomolar range has been accomplished.103  Western blotting can 
detect greater than 100 pg of protein while LC-MS/MS permits detection of 
proteins on the order of subpicograms.104,105 
 
When determining the mineral amount and composition within the hybrid 
constructs, colorimetric and spectroscopic assays have been applied.  
Quantifying the amount of calcium phosphate mineral present within the 
construct has been accomplished by the colorimetric calcium and phosphate 
assays.51,76  However, these assays cannot accurately determine what form of 
calcium phosphate is present.  This issue is addressed with several techniques 
including X-ray diffraction (XRD), Fourier transform infrared spectroscopy (FTIR), 
NMR, energy dispersive X-ray spectroscopy (EDX), or X-ray photoelectron 
spectroscopy (XPS) to determine the chemical composition and crystallinity of 
the minerals (Figure 2.4).13,22,39  Each type of mineral presents a unique 
spectrum or diffractogram in each of these analyses, thus allowing for 
identification of the specific minerals present.106 
 
Several methods have been used to determine the physical characteristics of the 
constructs.  Contact angle measurements can be used to quantitatively 
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demonstrate that the surface has been altered.  Water placed onto the surface of 
a construct forms a droplet, and the hydrophobicity of the surface can be 
predicted based on the angle that the droplet of water makes with the surface.  
This is especially useful when a hydrophobic scaffold material is coated with a 
hydrophilic substance such as HAp or collagen.  Micro-computed tomography 
(µCT) and fluid replacement methodologies have been used to determine the 
porosity of the constructs.14,54,65  µCT uses X-rays to visualize sections of radio-
opaque materials and uses a computer to reassemble the sections into a 3-D 
rendering of the construct.107  Using this representation, the interconnectivity of 
the pores, pore size, and porosity can be calculated.107  The fluid replacement 
methodologies, such as mercury porosimetry, gas pycnometry, and liquid 
intrusion, measure the change in initial fluid volume when the pores of the 
constructs are filled by the various fluids, which in turn is used to calculate the 
construct pore size and porosity.108 
 
2.3 In Vitro Cell Culture on Hybrid Constructs 
Following the synthesis and characterization of a hybrid construct, the 
assessment of its bone repair potential is an important step in establishing the 
cytocompatibility and osteogenicity of the material.  Typically, the initial 
characterization is through in vitro cell culture, since it is a less intensive method 
of determining the bone repairing potential as compared to in vivo implantation.  
Through the attachment and proliferation of cells onto the hybrid constructs, the 
cytocompatibility of the material can be elucidated.  Increased cellular attachment 
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and proliferation may suggest that if the hybrid construct is implanted, 
osteoblasts and stem cells will be able to successfully invade and colonize it.  
Furthermore, an increase in osteoblastic gene expression, protein secretion, and 
construct mineralization can demonstrate its osteogenicity.  The osteogenic 
differentiation of the cells within the hybrid construct in vitro suggests that once it 
is implanted, stem cells migrating from the surrounding tissue may be able to 
differentiate down an osteogenic pathway and contribute to bone regeneration in 
vivo. 
 
2.3.1 Cellular Attachment and Viability on Hybrid Constructs 
Several cell types have been cultured on hybrid constructs to determine their 
overall cytocompatibility.  These cell types include cell lines such as MC3T3-E1, 
mouse marrow stromal cells (D1 cell line), human fetal osteoblasts (hFOBs), and 
SaOS-2 or stem cells such as adipose derived stem cells (ADSCs) and MSCs 
from human, rat, and mouse sources.  An advantage of cell lines is that they are 
easily procured and cultured.  However, with the exception of MC3T3-E1 and D1 
cells, the cell lines are already differentiated into osteoblasts and thus can only 
provide limited information regarding the osteoinductivity of the hybrid construct.  
Notwithstanding, certain stem cell populations present the potential to 
differentiate down the osteoblastic lineage and may be useful in assessing the 
osteogenicity of a hybrid construct. 
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The viability and proliferation of the cultured cells can be determined by a variety 
of assays.  For instance, the lactate dehydrogenase assay quantifies the number 
of dead cells, while the PicoGreen assay determines the total amount of dsDNA 
which then can be used to calculate the number of cells if the amount of dsDNA 
has been measured for a known number of cells.  In addition, the 3-(4,5-
dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-sulfophenyl)-2H-
tetrazolium (MTS), 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide 
(MTT), and glucose consumption assays measure the metabolic activity of the 
viable cells. 
 
Cell lines cultured on hybrid constructs generally demonstrate a higher 
attachment and proliferation as compared to cell lines cultured on the 
corresponding scaffold material in the absence of an ECM component.13,14,16,29,32  
Li et al. determined that MC3T3-E1 cells cultured on electrospun PCL coated 
with collagen and calcium phosphate demonstrated significant enhancement in 
proliferation at day 7 when compared to cells seeded onto unmodified 
electrospun PCL fiber meshes.13  Additionally, the surface of the construct was 
covered with multiple layers of cells due to proliferation.  MC3T3-E1 cells were 
also shown to have faster attachment, higher degree of cell extension, and 
flattened morphology after 30 minutes of incubation and a higher increase in cell 
number after 7 days of culture when seeded onto a mesoporous bioactive glass 
(MBG)-PCL-ECM coated construct as compared to a plain PCL scaffold.14   
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Similarly, stem cells are generally able to attach and proliferate on hybrid 
constructs.18,30,31,34,35,37,51,64  Human MSCs seeded onto hybrid 
chitosan/gelatin/HAp constructs displayed high cell proliferation and deep cell 
penetration under flow perfusion conditions.31  When mouse MSCs were cultured 
on films of PLGA/DBM or PLGA/ABM, they expressed a higher level of 
attachment than that of cells cultured on PLGA film alone.37  Also, rat MSCs 
seeded onto hybrid titanium and cell-generated ECM constructs and hybrid PCL 
and cell-generated ECM constructs exhibited cell proliferation until day 18 or day 
8, respectively, with a subsequent drop at later timepoints.18,51,64  The 
investigators explained both drops at the later timepoints as being caused by the 
MSCs encasing themselves in matrix, preventing the DNA from being released 
into the analysis solution and being detected. 
 
The information gleaned from the cell attachment and viability studies can be 
used to guide hybrid construct composition.  For example, low cell viability may 
suggest that a component of the construct is cytotoxic and should be excluded, 
whereas cell attachment, maintenance of viability, and proliferation generally 
indicate cytocompatibility.  Each type of hybrid construct reviewed herein has 
been observed generally to demonstrate cellular attachment, viability, and 
proliferation.  Accordingly, these hybrid constructs demonstrate cytocompatibility 
and may support cell infiltration and survival in vivo. 
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2.3.2 Osteogenic Differentiation of Stem and Pre-osteoblastic Cells on 
Hybrid Constructs 
The differentiation of stem cells such as ADSCs and MSCs from human and rat 
sources and pre-osteoblastic cells such as MC3T3-E1 cells cultured on the 
constructs can be used to determine their osteogenicity.  Use of media 
containing osteogenic supplements has been shown to cause osteogenic 
differentiation of the stem and pre-osteoblastic cells.109  Thus, the true test of the 
osteogenicity of the construct is through culture in media without osteogenic 
supplements, such as dexamethasone.  This can be measured by the alkaline 
phosphatase (ALP) activity, an early stage marker of osteoblastic differentiation; 
gene expression of osteoblastic markers of the seeded cells; and the amount of 
osteocalcin, osteopontin, as well as mineral deposition present in the construct, 
all of which are late stage markers of osteoblastic differentiation.110-112 
 
The alkaline phosphatase activity of cells seeded onto several hybrid constructs 
were seen to be increased when compared to cells seeded on the base material 
lacking the biological components.14,18,31,34,51,64  However, even with osteogenic 
supplementation, Thomas et al. demonstrated that D1 cells cultured on the 
mixture of PLLA beads and DBM particles had a significantly lower ALP activity 
as compared to the cells cultured on PLLA beads alone.16  Additionally, Hild et al. 
showed that human MSCs cultured on composite calcium 
phosphate/collagen/PLGA films displayed no significant difference in ALP activity 
when compared to PLGA films.35 
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The upregulation in the production of osteopontin has also been observed in 
MSCs cultured onto chitosan/gelatin/HAp constructs.31  Similarly, MSCs cultured 
onto hybrid TCP/alginate/gelatin constructs exhibited enhanced osteopontin and 
osteocalcin production, and this was observed in both the presence and absence 
of the osteogenic supplement, dexamethasone.30 
 
Significantly higher gene expression of osteogenic markers such as runt-related 
transcription factor 2 (RUNX2), Collagen I, ALP, osteopontin, BMP-2, VEGF, 
FGF, aggrecan, and matrix metalloproteinase 9 (MMP-9) was observed for 
MC3T3-E1 cells and MSCs cultured on hybrid constructs in media with or without 
dexamethasone as compared to cells cultured on their respective base materials 
alone.14,74  However, in the case of a construct composed of PLLA beads and 
DBM particles, there was significantly lower gene expression by the seeded D1 
cells for bone sialoprotein (BSP), RUNX2 and osteocalcin as compared to the 
cells cultured on PLLA beads alone.16   
 
Many of the hybrid constructs also demonstrated a significantly higher amount of 
calcium mineralization than their base material counterparts.18,30,34,35,51,64  In 
particular, the TCP/alginate/gelatin constructs showed an increase in calcium 
mineralization even in the absence of the osteogenic supplement 
dexamethasone.30  The presence or lack of osteogenic differentiation of stem 
cells observed for the varying hybrid constructs does not seem to implicate any 
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specific combination of components.  Interestingly, even the presence of the 
osteogenic supplement dexamethasone does not guarantee differentiation.  
However, the one study that resulted in lower gene expression of osteogenic 
markers and ALP activity did not contain any form of calcium phosphate.16  The 
existence of a form of calcium phosphate may be necessary for proper 
osteogenic differentiation of the stem cells. 
 
The implications from the osteogenic differentiation studies can also be used to 
improve hybrid construct composition for bone repair.  A decrease in activity and 
amount of early and late osteogenic markers may signify that the construct 
components are not osteogenic, while an increase might suggest the potential of 
the constructs to promote bone repair in vivo.  Evaluation of the hybrid constructs 
reviewed herein demonstrates that all of the cell-generated ECM-based hybrid 
constructs have an increase in osteogenic markers as compared to their base 
material.  Meanwhile a few of the polymeric constructs incorporating collagen 
and calcium phosphate and the biological tissue ECM hybrid constructs 
demonstrate decreased osteogenic markers compared to their respective base 
materials.  The results of the in vitro studies indicate that the cell-generated 
ECM-based hybrid constructs may enhance bone formation and osteointegration, 
while those with decreased osteogenic markers may perform less favorably. 
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2.4 In Vivo Implantation of Hybrid Constructs 
Although an in vitro evaluation reveals important information regarding the 
cytocompatibility and osteogenicity of the constructs, the in vivo implantation of 
the hybrid constructs allows for the evaluation of their performance in the 
ultimately desired environment.  Implantation of these hybrid constructs can take 
place at an ectopic site, such as in muscle or under the skin, or at an orthotopic 
site, including sites in the cranium or on the femur.  Ectopic implantation occurs 
at a site where the tissue is not normally found and can be used to evaluate 
cytotoxic and inflammatory responses as well as the osteoinductivity of the 
construct.113  Orthotopic implantation occurs at a site where the tissue is normally 
found and provides information regarding the integration of the construct with 
surrounding tissue along with how well it assists in the union of an otherwise non-
healing bone defect.114 
 
2.4.1 Ectopic Implantation 
Analysis of a construct implanted at an ectopic site provides insight regarding the 
response of the body to the foreign object.  Implants are typically excised, fixed, 
sectioned, and stained for the identification and quantification of inflammatory 
cells.  Bone formation within the constructs has also been visualized using 
radiological imaging, by histology, and by immunohistochemistry for bone 
markers.36,69,81  Hybrid constructs incorporating biological tissue ECM and 
constructs containing cell-generated ECM have been implanted ectopically and 
analyzed for bone formation and inflammatory response.15,36,39,69,70,79,81 
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2.4.1.1  Acellular Hybrid Constructs 
Biological tissue ECM hybrid constructs have tended to exhibit a high initial 
inflammatory response that drops at later timepoints.15,39  ABM and PEG-PCL-
PEG hybrid constructs were injected subcutaneously into the back of mice and 
excised at 1, 2 and 4 weeks.39  The number of inflammatory cells was high in 
both PEG-PCL-PEG scaffolds and ABM/PEG-PCL-PEG constructs at weeks 1 
and 2, but by week 4, the number had dropped significantly.  Similarly, composite 
UBS and PLGA constructs were placed into a subcutaneous pocket on the backs 
of mice for 7, 14, 28, and 56 days.15  The implants showed an inflammatory 
response with mixed cell populations at day 7, but by days 28 and 56, the 
inflammatory response was much less, with only the presence of mononuclear 
cells detected.  By the end of the implantation period, the PLGA portion of the 
construct was retained, although the UBS component was not identifiable.   
 
2.4.1.2  Cellular Hybrid Constructs 
Meanwhile, constructs containing cell-generated ECM have been typically 
analyzed for bone formation.69,70,79,81  Cell-generated ECM coated biphasic 
calcium phosphate constructs containing human BMSCs were implanted in 
subcutaneous pockets on the backs of mice for 6 weeks.69,70  The constructs 
demonstrated de novo bone formation with areas of mineralized bone and 
osteoids as well as the presence of osteocytes, osteoblasts, blood vessels, bone 
marrow, and fat cells in close proximity to newly formed bone.   
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Another study investigated the implantation of composite tooth and bone 
constructs composed of porcine cell-generated ECM-coated PLGA onto the 
omentum of rats for 8 weeks.81  The implants consisted mainly of alveolar bone-
like tissue found near the tooth portion, precursor osteoid tissue, and compact 
bone found at a distance from the tooth portion.  Collagen I, BSP, and 
osteocalcin were detected throughout the compact bone-like tissue, while only 
collagen I was found in the alveolar bone-like tissue, similar to that found in 
native porcine alveolar bone tissue. 
 
The hybrid construct incorporating tricalcium phosphate, PLGA, and gelled 
collagen was investigated for bone formation in a subcutaneous implantation 
model.36  The channels present in the construct were found to contain fibrous 
tissue, but the constructs were also surrounded and penetrated by new cortical 
bone. 
 
2.4.2 Orthotopic Implantation 
Analysis of a construct implanted at an orthotopic site allows for investigation of 
the integration of the implant material with the surrounding bone tissue and the 
ability of the construct to promote healing of the defect.114  Similar to ectopic 
implantations, orthotopic implants are typically excised, fixed, sectioned, and 
analyzed for the presence of inflammatory cells and bone formation.  The 
presence of inflammatory cells and bone formation within hybrid constructs has 
also been visualized by histology and immunohistochemistry.38,57  Additionally, 
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bone formation within hybrid constructs has been determined by staining with 
fluorescent dyes and X-rays of the implant.80,82,115  Cell-generated ECM 
constructs and constructs incorporating biological tissue ECM have been 
implanted orthotopically and analyzed for inflammatory response and bone 
formation in both small and large animals.38,57,80,82,115,116 
 
2.4.2.1 Acellular Hybrid Constructs 
Tour et al. investigated the bone formation and inflammatory response of 
acellular cell-generated ECM constructs.  HAp and rat calvarial osteoblast-
generated ECM constructs were implanted in critical-sized calvarial defects in 
rats for 12 weeks.57  The composite HAp and ECM constructs contained more 
new bone formation than HAp scaffolds alone, with the bone forming at the 
margins and in the central portion of the scaffold on the dural side.  However, no 
construct had completely restored the defect.  Each construct had similar staining 
patterns for BSP, osteopontin, and periostin, a cell-adhesion molecule for pre-
osteoblasts.117  BSP and osteopontin were found in HAp particles incorporated 
within the newly formed bone, whereas the periostin was found between the non-
integrated particles.  There was still a large active inflammatory response at 12 
weeks, but the composite HAp and ECM constructs demonstrated larger 
amounts of macrophages present near the non-integrated HAp particles than in 
the HAp scaffold alone.   
 
32 
 
In another study, biological tissue ECM hybrid constructs were examined by 
Kurikalli et al. for their orthotopic bone formation and inflammatory response.38   
A hybrid construct composed of Pluronic F-127, DBM, and rat MSCs was 
implanted into a critical-sized cranial defect in rats for 1 month.  At the study 
endpoint, the implants displayed a continuous layer of bone throughout the 
defect and integration with the defect edges.  The shape of the newly formed 
bone also showed exact conformity with the missing bone fragment, suggesting 
that the implanted MSCs remodeled the scaffolding.  There was no visible sign of 
inflammatory cells reported within the implant.   
 
2.4.2.2  Cellular Hybrid Constructs 
Titanium constructs containing rat MSCs along with their ECM coating were 
implanted in a critical-sized cranial defect in rats for periods of 1 week and 1 
month.116  After excision of the1 week implants, a thin fibrous capsule was seen 
surrounding the implant and exhibited no macroscopic sign of bone formation.  
Mineralized matrix was observed at the implant edges and at the periosteal side.  
Additionally, fibrous tissue with capillary infiltration was seen to be present 
throughout the implant.  In the 1 month implants, there were osteocytes 
embedded within a mineralized matrix that had osteoids, osteoblasts covering 
the surface, and bone marrow present within the titanium fiber mesh.  Some of 
the implants were seen to have a connection of bone across the defect, but a 
large variability in the amount of bone formation was found in each implant.  
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Implantation in animals larger than rats was explored by Steigman et al. through 
the implantation of electrospun PLLA constructs containing rabbit amniotic MSCs 
and their ECM coating into sternal defects of rabbits.80  X-ray images of the 
implant at 8 weeks showed that there was radio-opaque material covering the 
constructs with complete closure of the defect.  The constructs demonstrated 
substantial engraftment and typical bone morphology, with very little 
inflammatory cells present.  The implants demonstrated similar amounts of 
mineralization before implantation and after the 8 week implantation period, but 
there was an increase in ALP activity in the 8 week post-implantation constructs 
when compared to pre-implantation constructs.   
 
Even larger animals than rabbits have received hybrid construct implants.  Zhang 
et al. implanted composite tooth and bone constructs comprised of porcine cell-
generated ECM coated PLGA into the mandible of pigs for 12 weeks or 20 
weeks.82  Radiographs and ultra high-resolution volume computed tomography 
(VCT) images of the excised implants were taken to determine the density of the 
regenerated tissue.  Radiographs and VCT images demonstrated that the 20 
week implants had denser bone than the 12 week implants.  They also 
demonstrated that the scaffolds without the cell-generated ECM or cells did not 
exhibit any mineralization.  Histology showed complete bony bridge formation on 
both the buccal and lingual sides of the implant after 12 weeks.  Nevertheless, 
there was disorganized bone formation within the centers of the implants.  
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Immunohistochemistry demonstrated that the bony portion of the construct 
contained BSP and osteocalcin.   
 
Similar to the in vitro studies, a varying biological response was observed for the 
hybrid constructs in both small and large animals.  Nonetheless, the 
incorporation of MSCs within the hybrid constructs displayed greater bone defect 
closure than the hybrid constructs lacking cells.  Accordingly, these studies 
warrant further investigation into the use of hybrid constructs as a cell 
transportation vehicle for enhanced repair of bone defects. 
 
2.5 Conclusions 
The human body presents a limited natural ability to fully repair large bony tissue 
defects.  To improve current clinical treatments of non-healing bone defects, 
tissue engineers have been researching materials that can successfully integrate 
with the native bone and promote tissue repair.  This review discussed current 
approaches that have included the incorporation of several components found in 
native bone matrix in conjunction with a biomaterial that might otherwise be non-
osteogenic.  Methods of combining these components into a hybrid construct 
include coating a scaffold with collagen and a form of calcium phosphate, 
combining acellular biological tissue with a polymer, and creating a cell-
generated ECM coating on a scaffold.  These hybrid constructs have 
demonstrated an increase in overall performance in cell viability and proliferation, 
in vitro differentiation, and in vivo bone formation over synthetic materials alone.  
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Yet, the studies on hybrid constructs suggest that additional investigation into the 
essential components of a construct and the potential inclusion of cells within a 
construct will be necessary to improve their biocompatibility, osteogenicity, and 
repair potential. 
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Construct Type Methods of Synthesis References 
 
 
 
 
 
Polymeric 
constructs 
incorporating 
collagen and 
calcium phosphate 
Sequential deposition of collagen/gelatin and 
hydroxyapatite onto scaffold 
1.  Generate polymer scaffold 
     a) Electrospinning 
     b) 3D printing 
     c) Lyophilization 
2.  Coat scaffold with collagen or gelatin 
3.  Coat scaffold with hydroxyapatite 
 
 
13, 14, 22, 26, 
27 
Simultaneous incorporation of collagen/gelatin 
and calcium phosphate within scaffold 
1.  Combine polymer, collagen or gelatin, and 
     calcium phosphate 
2.  Remove solvent 
 
29-33 
Incorporation of collagen/gelatin within scaffold 
followed by deposition of calcium phosphate 
1.  Combine polymer with collagen or gelatin 
2.  Remove solvent 
3.  Coat scaffold with calcium phosphate 
 
 
 
34-36 
Incorporation of calcium phosphate within 
scaffold followed by deposition of collagen/gelatin 
1.  Combine polymer with calcium phosphate 
2.  Remove solvent 
3.  Coat scaffold with collagen or gelatin 
 
Biological tissue 
ECM-based 
construct 
1.  Decellularize biological tissue 
     a)  Bone matrix 
     b)  Urinary bladder submucosa 
2.  Pulverize the acellular tissue 
3.  Combine polymer and acellular tissue particles 
4.  Solidify 
 
 
15, 16, 37-39 
 
Cell-generated 
ECM-based 
construct 
1.  Seed cells on porous scaffolds 
     a)  Stem cells 
     b)  Pre-osteoblastic cells 
     c)  Osteoblasts 
2.  Culture cell-seeded scaffolds 
     a)  Static culture 
     b)  Flow culture 
     c)  Electromagnetic stimulation culture 
     d)  Dynamic strain culture 
 
 
17, 18, 51-57, 
63-77, 79-82, 
84, 88-94, 115, 
116 
 
Table 2.1:  Methods of synthesis for the three different types of hybrid constructs 
discussed within this manuscript, including polymeric constructs incorporating 
collagen and calcium phosphate, biological tissue ECM-based constructs, and 
cell-generated ECM-based constructs. 
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Figure 2.1:  Scanning electron micrograph of a hybrid construct combining a 
synthetic material with collagen and nanohydroxyapatite.  The construct was 
generated by initially electrospinning a PLLA/PBLG/collagen solution followed by 
3 cycles of soaking in a calcium chloride solution then in sodium phosphate 
dibasic solution.  The result was hydroxyapatite crystals covering collagen-like 
fibers.  Reproduced with permission.34 2012, Elsevier. 
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Figure 2.2:  Scanning electron micrograph of a hybrid construct composed of 
biological tissue ECM and a polymer, which incorporates ABM with PEG-PCL-
PEG at 20 wt%.  The arrows indicate a few of the ABM particles present within 
the construct.  Reproduced with permission.39 2011, John Wiley and Sons. 
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Figure 2.3:  Scanning electron micrograph of a hybrid construct which has a cell-
generated ECM coating on a fiber mesh scaffold.  Rat MSCs were seeded onto 
titanium fiber mesh scaffolds and cultured in osteogenic media for 16 days to 
generate the ECM visibly coating the fibers and filling the space in between.  
Reproduced with permission.68 2005, John Wiley and Sons. 
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Figure 2.4:  A SEM micrograph (A) of the surface of a cell-generated ECM-
based construct and its corresponding EDX elemental mapping (B).  The overlay 
of calcium (green), phosphorous (red), and titanium (blue) demonstrates that the 
calcium and phosphorous are co-localized on the titanium construct. Reproduced 
with permission.73 2009, John Wiley and Sons. 
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CHAPTER 3 
 
Osteogenic Differentiation of Mesenchymal Stem Cells on  
Pre-Generated Extracellular Matrix Scaffolds in the Absence of  
Osteogenic Cell Culture Supplements 
 
Abstract 
 
This study utilized a full factorial design to investigate the effect of four factors: 
presence of whole bone marrow cells, presence of in vitro-generated mineralized 
extracellular matrix, presence of dexamethasone, and variations in culture 
duration, on the proliferation and osteogenic differentiation of mesenchymal stem 
cells (MSCs) cultured on a polymer scaffold.  Electrospun poly(ε-caprolactone) 
(PCL) fiber mesh scaffolds were seeded with rat MSCs and cultured in complete 
osteogenic medium for 12 days to generate constructs containing mineralized 
extracellular matrix (ECM).  MSCs or MSCs and whole bone marrow cells were 
seeded onto decellularized extracellular matrix constructs (PCL/ECM) or plain 
PCL scaffolds, and cultured statically for 4, 8, and 16 days in medium either 
containing or lacking dexamethasone.  After each culture period, the cell number 
was determined by DNA analysis, while the osteogenic differentiation state of the 
cells was determined by alkaline phosphatase activity assay and calcium assay.  
MSCs seeded onto PCL/ECM constructs and cultured in medium either 
containing or lacking dexamethasone demonstrated similar amounts of calcium 
deposition after 16 days.  A significant increase in cell number over time 
compared to all other groups was observed when whole bone marrow cells were  
co-cultured with MSCs on PCL scaffolds in medium lacking dexamethasone.   
 
__________________________ 
* This manuscript was prepared as presented for submission to Tissue Engineering: Part A  
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This study establishes that the osteogenic differentiation of MSCs seeded onto 
ECM-containing constructs is maintained even in the absence of dexamethasone 
and that the co-culture of MSCs and whole bone marrow cells without 
dexamethasone and ECM enhances the proliferation of a cell population (or 
populations) present in the whole bone marrow. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
43 
 
3.1 Introduction 
Replacement of diseased or compromised bone tissue is often accomplished 
clinically with autologous bone grafts due to its osteogenic, osteoconductive, and 
osteoinductive capabilties.118-122  However, such drawbacks as donor site 
morbidity, persistent severe pain, and limited availability are commonly 
associated with autograft bone.119,121,123,124  Alternatives to autologous bone 
grafts are being investigated, including polymers, collagen sponges, ceramics, 
and metals.1,4,6,125  To investigate the osteogenicity of these potential bone graft 
materials, osteoprogenitor cells are cultured in vitro on scaffolds generated from 
the graft material and are analyzed for their effect on the osteogenic 
differentiation and proliferation of the seeded osteoprogenitor cells.126-129  
Research in our laboratory has previously demonstrated that a titanium mesh 
and extracellular matrix (ECM) composite scaffold was conducive to the 
osteogenic differentiation and proliferation of mesenchymal stem cells (MSCs), 
an osteoprogenitor cell population.51,64  
 
In the bone marrow cavity, osteoprogenitor cells are in contact with other bone 
marrow cell populations, mineralized ECM, and biological factors.130-133  The co-
culture of MSCs with other bone marrow cell populations, including vascular 
endothelial cells, hematopoietic stem cells, hematopoietic progenitor cells, and 
osteoblasts, has been investigated for its effect on the osteogenic differentiation 
of the MSCs.134-137  As well, culturing of MSCs on mineralized ECM and with a 
variety of growth factors including TGF-β1, FGF-2, and BMP-2 have been 
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explored for their effect on the proliferation and osteogenic differentiation of 
MSCs.51,74,118,138-141  Furthermore, the supplementation of the culture medium 
with the corticosteroid dexamethasone has been investigated for its necessity in 
promoting the osteogenic differentiation of osteoprogenitor cells cultured in 
vitro.68,142  However, the co-culture of other bone marrow cell populations with 
MSCs in a three-dimensional mineralized ECM and with dexamethasone medium 
supplementation has not been explored. 
 
To address this issue, we utilized a full factorial study design by culturing MSCs 
in a three-dimensional poly(ε-caprolactone) scaffold in the presence of four 
factors i) whole bone marrow cells, ii) in vitro-generated mineralized ECM, iii) 
dexamethasone, and iv) variations in culture duration.  The focus of this study 
was to elucidate the effects and potential interactions of the four factors on the 
proliferation and osteogenic differentiation of MSCs in a three-dimensional 
environment. 
 
3.2 Methods and Materials 
3.2.1 Fabrication of PCL Scaffolds 
Poly(ε-caprolactone) (PCL) (MW= 80000, Sigma, St. Louis, MO) was dissolved in 
a 5:1 (vol/vol) chloroform:methanol solution at 12 wt% (wt/wt).  The PCL solution 
was electrospun as previously described to fabricate fiber mesh mats that were 
approximately 1 mm thick, with approximately 5 µm average fiber diameters.143  
PCL scaffolds were prepared by die-punching 8 mm diameter discs from the 
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electrospun mats.  The scaffolds were then sterilized by exposure to ethylene 
oxide (Andersen Sterilizers Inc., Haw River, NC) for 14 hours, followed by aseptic 
aeration in a laminar flow cell culture hood, pre-wetted one day prior to cell 
seeding using an ethanol gradient series, and stored in sterile-filtered (0.22 µm) 
Millipore water until use. 
 
3.2.2 Mesenchymal Stem Cell Isolation 
Mesenchymal stem cells were harvested and pooled from the marrow of tibiae 
and femora of 5 male Fischer 344 rats (126 – 150g; Charles River Laboratories, 
Wilmington, MA) as previously described.68  Care of the rats in this study was in 
accordance with the Rice University Institutional Animal Care and Use 
Committee.  Briefly, rats were anesthetized using 4% isofluorane (Baxter 
Healthcare Corporation, Deerfield, IL) in O2 and subsequently euthanized by CO2 
asphyxiation followed by a bilateral thoracotomy to ensure death.  The tibiae and 
femora were aseptically removed and placed in Dulbecco’s Modified Eagle’s 
Medium (Invitrogen, Carlsbad, CA) with 10% Fetal Bovine Serum (FBS) 
(Cambrex BioScience, Walkersville, MD) and 3% penicillin-streptomycin-
fungizone (Invitrogen).  The epiphyses were cut, the diaphyses were pierced with 
a sterile 16 gauge needle, and the marrow was flushed out with 5 mL of complete 
osteogenic medium containing α-MEM (Invitrogen), 10% FBS (Cambrex 
BioScience), 10 mM β-glycerol-2-phosphate, 10 nM dexamethasone, 50 µg/mL 
ascorbic acid, 50 µg/mL gentamicin, 100 µg/mL ampicillin, and 0.5 µg/mL 
fungizone (Sigma).  The collected marrow pellets were broken up by trituration, 
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and the cell suspension was plated in 75 cm2 tissue culture flasks and cultured at 
37oC in a humidified atmosphere of 95% air and 5% CO2 until confluency.  The 
medium was aspirated after 1 day to remove the non-adherent cell population 
and was replaced with complete osteogenic medium.  Subsequent medium 
exchanges were performed every 2 days.  In this study, we designate the 
adherent cell population as “mesenchymal stem cells,” given the established 
osteogenic potential of these cells under proper culture conditions.144  When the 
cells reached confluency, they were lifted using 2 mL of 0.25% (vol/vol) trypsin 
solution (Sigma), centrifuged at 1000 rpm for 10 minutes, and resuspended in 
complete osteogenic medium at a concentration of 1.25 million cells/mL.   
 
3.2.3 Generation of PCL/ECM Scaffolds 
Prior to cell seeding, pre-wetted PCL scaffolds were transferred into complete 
osteogenic medium for 2 hours, press-fit into polymethylmethacrylate (PMMA) 
cassettes, and maintained in the incubator.  A quarter million of the isolated 
MSCs in 200 µL of complete osteogenic medium were seeded onto each PCL 
scaffold, and the MSCs were allowed to adhere to the scaffold for 2 hours in the 
incubator.  The scaffolds were then removed from their cassettes and placed in 
individual wells of a 12-well tissue culture polystyrene plate with 3 mL of 
complete osteogenic medium per well, which was exchanged every 2 days.   At 
day 12, the scaffolds were collected and individually placed into 1.5 mL of sterile-
filtered Millipore water.  The MSCs that produced the in vitro-generated ECM in 
the PCL scaffolds were then removed by a previously described decellularization 
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process, which involved 3 cycles of freezing in liquid N2 and thawing in a 37oC 
water bath, followed by 10 minutes of ultrasonication.51,64  The resulting acellular 
PCL/ECM scaffolds were then aseptically dried in a laminar air flow cell culture 
hood and sterilized by exposure to ethylene oxide (14 hours) for later use. 
 
3.2.4 Four Factor Experimental Design 
The groups investigated in this study can be found in Table 3.1.  For the acellular 
scaffold group, 6 acellular PCL/ECM scaffolds per culture duration were press-fit 
into PMMA cassettes, incubated with 200 µL of complete osteogenic medium 
(+media) for 2 hours, then removed to a fresh 12-well tissue culture polystyrene 
plate with 2 mL of +media per well.  For the groups seeded with MSCs alone, 6 
acellular PCL and 6 acellular PCL/ECM scaffolds per culture duration were 
press-fit into PMMA cassettes and seeded with 250,000 MSCs in 200 µL of either 
+media or complete osteogenic medium lacking dexamethasone (-media).  The 
cells were allowed to adhere for 2 hours in the incubator, and the scaffolds were 
removed to 12-well tissue culture polystyrene plates with 2 mL of either +media 
or -media per well, accordingly.  For the groups seeded with both MSCs and 
whole bone marrow, 6 acellular PCL and 6 acellular PCL/ECM scaffolds per 
culture duration were seeded with MSCs as stated above, but were left in the 
PMMA cassettes for 1 day in a 12-well tissue culture polystyrene plate with 2 mL 
of either +media or -media per well and were incubated in a humidified incubator, 
accordingly.  The following day, whole bone marrow was isolated from rat tibiae 
and femora using +media or –media and triturated, then 250,000 cells from the 
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whole bone marrow suspension in 200 µL of +media or -media, accordingly, 
were seeded onto the MSC-seeded PCL and PCL/ECM scaffolds.  The cells 
were allowed to attach for 2 hours, and the scaffolds were removed to fresh 12-
well tissue culture polystyrene plates with 2 mL of either +media or -media per 
well, accordingly.  The approximate number of MSCs, defined as the adherent 
cell population in whole bone marrow, present within the whole bone marrow 
suspension was determined by counting the number of cells attached to one 
tissue culture flask after 4 hours of incubation from a pool of 10,000,000 seeded 
whole bone marrow cells.  After averaging the results from 6 flasks, 
approximately one MSC was observed to be attached for every 1000 plated 
whole bone marrow cells (data not shown), thus approximately 250 MSCs were 
present in the 250,000 marrow cells that were seeded onto the respective 
scaffolds. 
 
3.2.5 Osteogenic Differentiation Assays 
At the 4, 8 and 16 day culture durations, four scaffolds from each group were 
individually placed into 1.5 mL of sterile-filtered Millipore water, and frozen at -
20oC for later analysis.  Each scaffold underwent 3 cycles of freezing and 
thawing followed by ultrasonication to lyse the cells and was assayed for 
cellularity, alkaline phosphatase (ALP) activity, and calcium content.  The 
cellularity of the seeded scaffolds was determined with the PicoGreen assay kit 
(Molecular Probes, Eugene, OR).  Briefly, 50 µL of cell lysate solution, 100 µL of 
Tris-EDTA (TE) buffer, and 150 µL of PicoGreen dye buffer were pipetted into an 
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opaque 96-well plate, with each sample performed in triplicate, and allowed to 
incubate at room temperature for 10 minutes in the dark.  The excitation of the 
solution at 485 nm and fluorescence measurement at 528 nm was performed 
using a FL X800 microplate spectrophotometer (Bio-Tek Instruments, Winooski, 
VT).  A conversion factor of 6.4 pg of DNA per cell was used to calculate 
cellularity and was based on DNA extracted from known numbers of MSCs (data 
not shown).  The alkaline phosphatase activity was measured using 1.5 M 
alkaline buffer solution and phosphatase substrate capsules (Sigma), and 
compared to dilutions of a 10 mM p-nitrophenol standard solution (Sigma).  
Briefly, 80 µL of the cell lysate solution, 100 µL of the substrate solution and 20 
µL of the buffer solution were added to a transparent 96-well plate, with each 
sample performed in triplicate, and allowed to incubate at 37oC for 1 hour.  The 
reaction was then stopped with 100 µL of 0.3 NaOH, and the absorbance was 
measured at 405 nm on a PowerWave X340 microplate spectrophotometer (Bio-
Tek Instruments).  After determining the cellularity and ALP activity, a volume of 
1 N acetic acid equal to the volume remaining in each sample tube was added to 
each cell lysate solution and scaffold.  The resulting 0.5 N acetic acid/cell lysate 
solution was placed on a shaker table for 1 day at 100 rpm to dissolve calcium 
present in the scaffold.  The calcium content of the scaffolds was then 
determined by adding 20 µL of the acetic acid/cell lysate solution and 300 µL of 
calcium assay reagent containing Arsenazo III (Diagnostics Chemicals Limited, 
P.E.I. Canada) to a transparent 96-well plate, with each sample performed in 
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triplicate.  The absorbance was then measured at 650 nm on a PowerWave 
X340 microplate spectrophotometer (Bio-Tek Instruments). 
 
3.2.6 Scanning Electron Microscopy 
One acellular PCL scaffold and one acellular PCL/ECM construct were fixed with 
2.5% glutaraldehyde solution (Sigma) at room temperature for 2 hours and rinsed 
3 times in PBS (Invitrogen).  The scaffolds were then dehydrated in a gradient 
ethanol series, air dried in a laminar air flow cell culture hood, lyophilized, and 
sputter coated with gold prior to imaging.  Each scaffold was imaged using a FEI 
Quanta 400 ESEM FEG (FEI Company, Hillsboro, OR) at 500 magnification in 
the center of each scaffold. 
 
3.2.7 Statistical Analysis 
Results are presented as means ± standard deviations.  Statistical significance 
was determined using Tukey’s Honestly Significant Differences test with a 95% 
confidence interval with JMP IN 5.1 software (SAS Institute Inc., Cary, NC), and 
global effects were determined using four-factor ANOVA with SAS system 
software (SAS Institute Inc.). 
 
3.3 Results 
3.3.1 Global Factor Effects 
Table 3.2 demonstrates the significance of each of the global factors.  The 
seeding of whole bone marrow cells with MSCs onto the scaffolds was found to 
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have a significant effect (p<0.05) only in the case of the overall cellularity of the 
scaffolds.  The presence of an ECM in the PCL scaffolds and the presence of 
dexamethasone each resulted in a significant effect (p<0.05) upon the ALP 
activity and the calcium deposition onto the scaffolds, although no significance 
was observed for cellularity in either case.  The culture duration had a significant 
effect (p<0.05) upon the calcium deposition onto the scaffolds. 
 
3.3.2 Cellularity of the Scaffolds 
Table 3.1 clarifies the abbreviations for the groups investigated in this study.  As 
can be seen in Figure 3.1, there was a trend for the cellularity of the scaffolds to 
increase at day 8 and then to decrease by day 16 for four groups, PCL MSCs+, 
PCL/ECM MSCs+, PCL/ECM MSCs-, and PCL/ECM Co-culture-.  In addition, 
there was a trend for the cellularity to decrease with time for the PCL Co-culture+ 
and PCL/ECM Co-culture+ groups.  However, the PCL Co-culture- group 
demonstrated a significant increase (p<0.05) in cellularity at day 16 as compared 
to day 4, unlike any other group investigated.   
 
3.3.3 Alkaline Phosphatase Activity 
As illustrated in Figure 3.2, a significantly greater (p<0.05) ALP activity was 
observed at day 8 for scaffolds cultured in +media as compared to the 
corresponding groups cultured in -media.  The PCL Co-culture+ and PCL/ECM 
Co-culture+ groups demonstrated a significantly greater (p<0.05) ALP activity 
than the corresponding groups seeded with MSCs alone at day 8.  Additionally, 
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there was a trend for a peak in ALP activity at day 8 for all groups except for the 
acellular, PCL MSCs+, PCL MSCs-, and PCL/ECM Co-culture- groups. 
 
3.3.4 Calcium Deposition 
Figure 3.3 illustrates that the amount of calcium deposited significantly increased 
(p<0.05) over time for all groups, excluding the PCL MSCs- and PCL Co-culture- 
groups.  Both the PCL MSCs- and PCL Co-culture- groups demonstrated 
minimal calcium deposition.  The calcium deposition at day 16 for the PCL/ECM 
Co-culture+ and PCL/ECM Co-culture- groups were similar to the corresponding 
groups seeded with MSCs alone.  Interestingly, significantly increasing (p<0.05) 
calcium deposition was observed over time for the acellular group. 
 
3.3.5 Scanning Electron Microscopy 
Figure 3.4 illustrates that the PCL/ECM constructs are coated with a surface 
layer of extracellular matrix after 12 days of culture with MSCs.  Cracks in the 
surface layer of the dried ECM reveal uncoated electrospun PCL fibers 
underneath. 
 
3.4 Discussion 
The goal of this study was to determine the effect and interactions of four culture 
factors i) the presence of whole bone marrow cells, ii) the presence of in vitro-
generated mineralized ECM, iii) the presence of dexamethasone, and iv) 
variations in culture duration on the proliferation and osteogenic differentiation of 
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MSCs cultured on an electrospun PCL scaffold.  The MSCs used in this study 
have been characterized in a previous study and adherent marrow cell 
populations (MSCs) have been widely studied in bone tissue engineering.70,145-147  
Although cell markers were not utilized to directly measure osteogenic 
differentiation of the MSCs, two well-established and accepted biochemical 
markers, alkaline phosphatase activity and calcium deposition, were 
assessed.148,149  
 
Each of the four factors had an effect on the cellularity, alkaline phosphatase 
activity, and calcium deposition of the MSC-seeded scaffolds.  Co-culture of 
whole bone marrow cells with the MSCs resulted in a significant global effect on 
the cellularity of the scaffolds and is attributable to the increased total number of 
cells seeded onto these scaffolds.  The other three factors were found to globally 
affect the alkaline phosphatase activity of the seeded cells and the calcium 
deposition onto the scaffolds, and are consistent with the results from our 
previous studies using sintered titanium mesh scaffolds.51,64,67,68   
 
The results for the PCL MSCs+ and PCL/ECM MSCs+ groups are also similar to 
the results from our previous studies using sintered titanium mesh 
scaffolds.51,64,67,68  Both groups demonstrated an increase in cellularity at day 8 
with a decrease at day 16, a peak in ALP activity at day 8, a trend for greater 
ALP activity in +media as compared to -media, and a significant increase in 
calcium deposition over time. The presence of dexamethasone is well-known to 
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initiate differentiation of MSCs towards the osteogenic lineage.68,150-153  An early 
stage marker of the osteogenic differentiation of MSCs is an increase in ALP 
activity, while later stages are marked by the deposition of calcium phosphate.11  
The peak in ALP activity observed at day 8 for the majority of groups investigated 
reflects that the MSCs have begun to differentiate along the osteogenic lineage, 
while the drop in ALP activity and increase in calcium deposition at day 16 
indicate that the MSCs have reached late stages of osteogenic differentiation.  
Together, the data demonstrate that an in vitro-generated mineralized ECM, 
medium supplementation with dexamethasone, and longer culture durations 
encourage osteogenic differentiation of MSCs cultured on electrospun PCL fiber 
mesh scaffolds, a biodegradable and hydrophobic material, and this result is 
consistent with MSCs cultured on sintered titanium mesh scaffolds, a non-
degradable and hydrophilic material. 
 
An increase in cellularity over time was observed for the PCL Co-culture- group.  
This increase in scaffold cellularity can be partially explained by the greater total 
number of cells seeded than in groups with MSCs alone.  However, the 
increased number of cells over time cannot be fully explained by the higher 
seeding density.  The PCL Co-culture+ group demonstrated a decrease in the 
number of cells present, although there was a similar amount of cells present in 
the scaffold in either media condition at day 4.  It is known that dexamethasone 
reduces the proliferation of MSCs, while increasing their osteogenic 
differentiation.154  Thus, the lack of dexamethasone in the culture medium for the 
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PCL Co-culture- group may have allowed the MSCs to proliferate.  Another 
explanation for the observed proliferation of the cells in this group was the low 
amount of calcium present in the scaffolds from this group at any time point.  Low 
amounts of calcium in the scaffold indicates that the matrix has not mineralized, 
thus after cell lysis, the cellular DNA was not trapped within a mineralized matrix 
surrounding the cell and was likely released in its entirety into the solution.  As a 
result, the complete cellular DNA could be detected during the DNA assay, 
potentially resulting in a higher cell number than the PCL Co-culture+ group.  
However, the PCL MSCs- group with its similarly low amount of mineralization 
did not demonstrate a significant increase in cellularity over time when compared 
to the PCL Co-culture- group.  These results imply that the lack of 
dexamethasone in the culture medium allowed for a cell population (or 
populations) present in the whole bone marrow to proliferate.  Indeed, in a paper 
by Dexter et al., in vitro culture of hematopoietic tissue was accomplished by 
culturing whole bone marrow cells on a layer of bone marrow-derived adherent 
cells in Fischer’s medium containing only FBS and antibiotics.155  As well, several 
studies have demonstrated that hematopoietic progenitor cells derived from bone 
marrow co-cultured with a marrow stromal cell line were able to differentiate into 
T Cells and B cells.156-158 
 
Significantly greater ALP activity was observed at day 8 for the PCL Co-culture+ 
group versus the PCL MSCs+ group as well as for the PCL/ECM Co-culture+ 
group versus the PCL/ECM MSCs+ group.  However, this result may be an 
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artifact of the decreasing number of cells over time for the co-culture groups, 
since only the differentiating MSCs are expected to produce ALP.  When the ALP 
activity is normalized to µmoles/hour/scaffold, there is no significant difference in 
the ALP activity at day 8 between the PCL MSCs+ and PCL Co-culture+ groups 
or between the PCL/ECM MSCs+ and PCL/ECM Co-culture+ groups (data not 
shown).  This implies that the whole bone marrow cells had no observable effect 
on the osteogenic differentiation of the MSCs seeded onto either type of 
scaffolds, as was suggested by the global effects.  The lack of any observable 
effect of co-culture with whole bone marrow on the osteogenic differentiation of 
MSCs may be due to the supporting role that MSCs provide.  It is known from in 
vitro experiments that MSCs produce an ECM that is supportive of 
hematopoeisis.155-158  Thus, instead of whole bone marrow cells affecting the 
osteogenic differentiation of the MSCs, the MSCs may be promoting 
hematopoietic engraftment of any HSCs/HPCs present within the whole bone 
marrow cell population. 
 
Significantly lower ALP activity was observed for the PCL Co-culture- and 
PCL/ECM Co-culture- groups as compared to the PCL Co-culture+ and 
PCL/ECM Co-culture+ groups.  Due to the lack of the osteogenic supplement 
dexamethasone in the culture medium for the -groups, the MSCs present on the 
scaffold were not able to differentiate down the osteogenic lineage as ably as the 
+groups. 
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By day 16, there were no significant differences between the amount of calcium 
deposition on PCL/ECM constructs seeded with either MSCs alone or MSCs with 
whole bone marrow cells and cultured in either media.  The similar calcium 
deposition levels suggest that the whole bone marrow cells had an insignificant 
effect on the late-stage differentiation of the MSCs, as was suggested by the 
global effects.  In addition, the minimal calcium deposition observed for the PCL 
MSCs- and PCL Co-culture- groups was expected, as neither dexamethasone 
nor in vitro-generated ECM was present to induce the cells to differentiate down 
the osteogenic lineage.   
 
Low cell numbers and a low ALP activity with no change over time was observed 
for the acellular group.  This indicates that no living cells were present on the 
scaffold, but residual DNA and ALP was retained within the scaffold.  Due to the 
lack of living cells present on the scaffold, the increase in calcium deposition over 
time for acellular PCL/ECM constructs was unanticipated.  An increase in 
calcium deposition was not observed in a previous study with acellular 
titanium/ECM constructs.51  In the current study, it is feasible that any remaining 
DNA, phospholipid cell fragments and ALP present on the scaffold could present 
nucleation sites for calcium deposition, resulting in the increase in calcium 
observed in this study.  However, it is also plausible that a component of the 
extracellular matrix present in the construct induced calcium deposition.  
Additional studies with acellular PCL/ECM constructs washed thrice with PBS, 
ultrasonicated for 10 minutes, and subsequently cultured in +media 
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demonstrated a linear increase in calcium deposition over time, while plain PCL 
scaffolds treated similarly showed no calcium deposition (data not shown).  The 
increasing calcium deposition on the acellular PCL/ECM constructs implies that 
the ECM construct itself is conducive to calcium deposition and may mineralize 
over time in vivo without cells.  Nevertheless, the calcium deposition observed at 
day 16 on cell seeded PCL/ECM constructs was significantly higher as compared 
to acellular constructs.  Thus, seeding MSCs onto the ECM constructs will be an 
integral part of future investigations of bone formation in vivo. 
 
Significantly lower calcium deposition at all time points was observed for the PCL 
MSCs+ and PCL Co-culture+ groups when compared to the PCL/ECM MSCs+, 
PCL/ECM Co-culture+, PCL/ECM MSCs-, and PCL/ECM Co-culture- groups.  
This was a result of the PCL/ECM constructs being generated by osteogenically 
differentiated MSCs with 12 days of culture prior to decellularization.  After 12 
days, the deposited matrix on the construct had already started to mineralize, 
thus each PCL/ECM construct contained approximately 0.4 mg of Ca2+ (data not 
shown) at the beginning of the second culture period, while the PCL scaffolds 
alone had none. 
 
Calcium deposition at each of the culture durations was found to be similar when 
seeded PCL/ECM constructs were cultured in either +media or -media.  
However, previous results from our laboratory have shown that when MSCs were 
seeded onto titanium/ECM constructs in -media, there was little calcium 
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deposited onto the constructs.51  Prior to seeding the MSCs onto the PCL/ECM 
constructs, isolation of the MSCs was performed by plating the whole bone 
marrow cells onto a tissue culture flask in +media and culturing the adherent cells 
until confluency, approximately 6 to 7 days, while the MSCs seeded onto the 
titanium/ECM constructs were isolated and expanded in -media for 6 days.  This 
implies that expansion of MSCs in medium containing dexamethasone may be 
sufficient to direct the MSCs towards the osteogenic lineage.  However, in order 
to maintain the osteogenic differentiation of the MSCs, either continued exposure 
to dexamethasone or an in vitro-generated ECM is necessary.  This is supported 
by the significant increase in calcium deposition observed over time for the PCL 
MSCs+ and PCL/ECM MSCs- groups, while no significant difference in calcium 
deposition over time was observed for the PCL MSCs- group.  The continued 
osteogenic differentiation of MSCs may be due to the retention of growth factors, 
secreted during the generation of the ECM scaffold, within the ECM present on 
the scaffold.   
 
The osteogenic differentiation of the MSCs observed in the PCL/ECM MSCs- 
group has implications for future in vivo experiments.  Continuous in vivo delivery 
of the corticosteroid dexamethasone, which is not naturally present in the body, 
is known to result in delayed wound healing, increased risk for infection, and 
diabetes mellitus, along with other side effects.159,160  Thus, is it desirable to 
avoid the in vivo delivery of dexamethasone to cell-seeded scaffold implants.  
The results from this study imply that when an in vitro-generated ECM is present 
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in the scaffold, it may not be necessary to deliver an osteogenic medium 
supplement such as dexamethasone in vivo to maintain the MSCs differentiation 
down the osteogenic lineage. 
 
The results of this study demonstrate that the presence of an extracellular matrix 
and dexamethasone are significant factors for the enhancement of the 
osteogenic differentiation of mesenchymal stem cells cultured in vitro in a three-
dimensional environment.  The characterization of the protein and mineral 
components present within the in vitro-generated ECM is important to 
understanding the proteins necessary to maintain the osteogenic differentiation 
of the MSCs and will be the subject of future studies.  Additionally, for future 
studies, it would be interesting to investigate the gene expression of select 
groups to provide greater insight into the observations from the present study.   
 
3.5 Conclusions 
The goal of this study was to determine the effect of four factors on the 
osteogenic differentiation and proliferation of MSCs.  Three factors, the presence 
of an in vitro-generated extracellular matrix contained within the electrospun PCL 
scaffolds, the presence of dexamethasone in the culture medium, and variations 
in the duration of culture were significant with regards to the osteogenic 
differentiation of MSCs.  However, the co-culture of whole bone marrow cells with 
MSCs did not significantly influence the osteogenic differentiation of the MSCs 
under the conditions tested.  This study establishes that the isolation and 
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expansion of MSCs in medium containing the osteogenic supplement 
dexamethasone initiates the osteogenic differentiation of the MSCs, and 
subsequent culture upon constructs containing an in vitro-generated ECM, even 
with the lack of dexamethasone in the culture medium, sustains the osteogenic 
differentiation of the cells.  Additionally, this study suggests that the co-culture of 
MSCs and whole bone marrow cells without dexamethasone or in vitro-
generated ECM enhanced the proliferation of either MSCs or another cell 
population (or populations) present within the whole bone marrow. The 
elucidation of the effects and interactions of the four factors illuminates the 
necessary conditions of maintaining the osteogenic differentiation and 
proliferation of MSCs within a three-dimensional environment. 
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Table 3.1:  Names of the groups investigated in this study.  The acellular group 
was taken as the control.  Each of the other groups represents one combination 
of the four factors: cells seeded, scaffold type, media composition, and duration. 
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Table 3.2:  Global effect of the four factors investigated in this study.  
Significance levels were determined by using four-factor ANOVA and Tukey’s 
HSD with the SAS system software.  Not significant is abbreviated as N.S. 
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Figure 3.1:  Cellularity of scaffolds seeded with MSCs or whole bone marrow 
cells and MSCs.  Cell numbers were determined with a PicoGreen assay kit and 
are represented as mean ± standard deviation with n = 4.  Groups not connected 
by the same letter are significantly different (p<0.05). 
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Figure 3.2:  Alkaline phosphatase activity of scaffolds seeded with MSCs or 
whole bone marrow cells and MSCs.  ALP activity was determined by 
absorbance spectroscopy and are represented as mean ± standard deviation 
with n = 4.  Groups not connected by the same letter are significantly different 
(p<0.05). 
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Figure 3.3:  Calcium ion amount present on scaffolds seeded with MSCs or 
whole bone marrow cells and MSCs.  Calcium amount was determined by 
absorbance spectroscopy and are represented as mean ± standard deviation 
with n = 4.  Groups not connected by the same letter are significantly different 
(p<0.05). 
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Figure 3.4:  Scanning electron micrographs of A) PCL scaffolds and B) 
PCL/ECM constructs at a magnification of 500X.  The scale bar represents 100 
µm. 
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CHAPTER 4 
 
Protein and Mineral Composition of Osteogenic Extracellular Matrix 
Constructs Generated with a Flow Perfusion Bioreactor 
 
Abstract 
This study investigated the temporal composition of an osteogenic extracellular 
matrix construct generated by culturing mesenchymal stem cells in an 
electrospun biodegradable poly(ε-caprolactone) fiber mesh scaffold within a flow 
perfusion bioreactor.  Constructs of different extracellular matrix maturities were 
analyzed for their protein and mineral composition at several culture durations by 
liquid chromatography-tandem mass spectroscopy, scanning electron 
microscopy, energy dispersive X-ray diffraction, X-ray diffraction, and calcium 
and phosphate assays.  The analysis revealed that at short culture durations the 
cells deposited cellular adhesion proteins as a prerequisite protein network for 
further bone formation.  At the later culture durations, the extracellular matrix was 
composed of collagen 1, hydroxyapatite, matrix remodeling proteins, and 
regulatory proteins.  These results suggest that the later culture duration 
constructs would allow for improved bone regeneration due to the ability to 
mineralize and the capabilities for future remodeling. 
 
 
 
 
 
__________________________ 
* This manuscript was prepared as presented for submission to Biomacromolecules  
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4.1 Introduction 
Bone defects can arise from a variety of sources, including trauma, resection of 
tumors, and congenital disorders.  Autograft bone stands as the gold standard 
material for reconstruction of the missing bony tissue, due to its ability to 
integrate with the surrounding bone and to grow with the patient.1,161  However, 
autograft bone is of limited availability and may present an associated donor site 
morbidity.162,163  Bone tissue engineering seeks to develop alternative materials 
to overcome the limitations of bone grafts by providing a supporting environment 
and incorporating bioactive and biomimetic domains found in mature bone to 
induce bone formation and regeneration. 
 
The organic phase of the extracellular matrix (ECM) of mature bone is composed 
largely of collagen 1, while the mineral component consists of hydroxyapatite.11  
Other proteins such as collagen 5, fibril-associated collagens, proteoglycans, 
glycoproteins, growth factors, and matrix metalloproteinases (MMPs) are present 
in minor quantities, but are also important components of the composition of 
bone.11  Collagen 5 and the fibril-associated collagens help regulate the correct 
fibril diameter of collagen 1 in the tissue.  The proteoglycans and glycoproteins 
bind to growth factors, nucleate hydroxyapatite deposition, and facilitate bone cell 
attachment.  Select growth factors promote osteoblast infiltration and blood 
vessel ingrowth into the bone, while the MMPs allow for the remodeling of bone.  
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Many bone tissue engineering scaffolds have been designed incorporating 
domains that mimic the varied components, structures, and bioactive nature of 
mature bone.  Examples include, prefabricated polymers also containing collagen 
with deposited apatite crystals, calcium phosphate cements with growth factor 
releasing microspheres, and gelatin hydrogels with adsorbed or absorbed growth 
factors.164-168  In our laboratory, we have investigated an osteogenic tissue 
engineered construct, comprising an electrospun poly(ε-caprolactone) (PCL) 
scaffold and an ECM coating generated by osteogenically differentiated 
mesenchymal stem cells (MSCs) cultured for 12 days within a flow perfusion 
bioreactor (PCL/ECM constructs).18,169  We have demonstrated that 
osteogenically pre-differentiated MSCs cultured on acellular PCL/ECM constructs 
retained their differentiation without the presence of osteogenic cell culture 
supplements.18,169  Moreover, these acellular PCL/ECM constructs supported 
continued mineralization in culture medium.18  These constructs were shown to 
contain the major bone components: collagens, glycosaminoglycans, and a 
calcium-bearing mineral.64,74 
 
In this study, we hypothesize that the ECM deposited by MSCs within the 
constructs cultured under flow perfusion conditions replicates the proteins and 
minerals found in mature bone and that there is a temporal effect in the 
deposition of these components during in vitro culture.  To test these hypotheses, 
we analyzed the protein and mineral compositions of in vitro MSC-generated 
ECM constructs at different culture durations after a decellularization and drying 
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procedure.  Electrospun PCL scaffolds were seeded with osteogenically pre-
differentiated MSCs and cultured within a flow perfusion bioreactor for 8, 12, and 
16 days in osteogenic differentiation medium.  Day 12 constructs were 
decellularized, dried, sterilized, reseeded with fresh pre-differentiated MSCs, and 
cultured in osteogenic medium within a flow perfusion bioreactor for an additional 
4, 8, and 16 days.  Each construct group was decellularized and air dried prior to 
imaging with scanning electron microscopy (SEM), protein analysis with liquid 
chromatography-tandem mass spectroscopy (LC-MS/MS), and mineral analysis 
with energy dispersive x-ray diffraction (EDX), x-ray diffraction (XRD), calcium 
assay, and phosphate assay. 
 
4.2 Materials and Methods 
4.2.1 Fabrication of PCL Scaffolds 
PCL with an inherent viscosity of 0.68 dL/g, number average molecular weight of 
61000 ± 2500 Da, and a weight average molecular weight of 88500 ± 2700 Da 
(DURECT Corporation, Pelham, AL) was dissolved in a 5:1 (vol/vol) 
chloroform:methanol solution at 22 wt% (wt/wt).  The PCL solution was 
electrospun as previously described to produce fiber mesh mats with a porosity 
of 84% and an average fiber diameter of approximately 5 µm, from which disc-
shaped scaffolds 8 mm in diameter and approximately 1 mm thick were prepared 
using a biopsy punch.143  The scaffolds were then sterilized by exposure to 
ethylene oxide (Andersen Sterilizers Inc., Haw River, NC) for 14 hours and pre-
wetted using an ethanol gradient one hour prior to cell seeding. 
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4.2.2 MSC Isolation 
MSCs were harvested and pooled from the marrow of tibiae and femora of 4 
male Fischer 344 rats (150 – 175 g; Charles River Laboratories, Wilmington, MA) 
as previously described.68  Care of the rats in this study was in accordance with a 
protocol approved by the Rice University Institutional Animal Care and Use 
Committee.  The MSCs were cultured in complete osteogenic media (α-MEM 
(Invitrogen, Carlsbad, CA), 10% FBS (Gemini Bio-Products, West Sacramento, 
CA), 10 mM β-glycerol-2-phosphate, 10 nM dexamethasone, 50 µg/mL ascorbic 
acid, 50 µg/mL gentamicin, 100 µg/mL ampicillin, and 0.5 µg/mL fungizone (all 
from Sigma-Aldrich, St. Louis, MO)) for 7 days to pre-differentiate them along the 
osteogenic pathway.68  Rat femora from select MSC isolations were cleaned of 
soft tissues and retained frozen in Millipore-filtered water for later mineral content 
analysis.   
 
4.2.3 MSC Culture on PCL Scaffolds 
Prior to cell seeding, seventy-eight pre-wetted PCL scaffolds were transferred 
into complete osteogenic medium for 2 hours, press-fit into cassettes, and 
maintained briefly in an incubator.  A quarter-million of the isolated MSCs in 200 
µL of complete osteogenic medium were seeded onto each PCL scaffold, and 
the MSCs were allowed to adhere to the scaffold overnight in the incubator.  
Subsequently, the scaffold-containing cassettes were placed into a flow perfusion 
bioreactor at a flow rate of 1 mL/min with 200 mL of complete osteogenic 
medium per bioreactor, which was exchanged every 2 days.61   Twelve 
73 
 
constructs each were removed from the bioreactors at day 8 (PCL day 8) and 
day 16 (PCL day 16), while a total of fifty-four constructs were removed at day 12 
(PCL day 12).  The MSCs that generated the osteogenic ECM in the PCL 
scaffolds in vitro were then removed by a decellularization process, which 
involved 3 cycles of freezing in liquid N2 and thawing in a 37oC water bath, 
followed by 10 min. of ultrasonication.  Forty-two of the day 12 constructs 
previously generated were aseptically air dried and sterilized for 14 hours in 
ethylene oxide (PCL/ECM constructs).  Six of the day 12 constructs (PCL/ECM 
0) were retained for LC-MS/MS analysis as a control for the remaining PCL/ECM 
constructs. 
 
4.2.4 MSC Culture on PCL/ECM Constructs 
Prior to seeding with fresh MSCs, acellular PCL/ECM constructs were transferred 
to complete osteogenic media for 2 hours, press-fit into cassettes, and 
maintained briefly in the incubator.  MSCs were seeded and cultured on the 
constructs as described in the previous section.  Twelve constructs each were 
removed from the bioreactors at day 4 (PCL/ECM day 4), day 8 (PCL/ECM day 
8), and day 16 (PCL/ECM day 16), and the reseeded MSCs were removed by 
the decellularization procedure described in the previous section. 
 
4.2.5 Protein Extraction 
Six constructs from each group were combined and minced with microscissors, 
then placed in 1.5 mL of 7 M urea buffer (7 M urea, 2 mM sodium EDTA, 50 mM 
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tris(hydroxymethyl)amino-methane, 0.5% triton X-100, 1% protease inhibitor 
cocktail, 2 mM dithiothreitol, 1 mM phenylmethylsulfonyl fluoride (all from Sigma-
Aldrich)) and rotated at 4oC overnight.  The solution was strained to remove PCL 
fragments, centrifuged at 2000 rpm for 10 min. to pellet the mineral components, 
and the supernatant containing the protein extract was aliquoted into two 750 µL 
samples and frozen at -20oC.   
 
4.2.6 LC-MS/MS Analysis 
One of the frozen 750 µL supernatant samples from each group was defrosted 
and analyzed at the proteomics core facility at M.D. Anderson Cancer Center via 
LC-MS/MS according to their standard operating procedure.  Briefly, the protein 
solutions were precipitated using an equal volume of 3.9 M ammonium sulfate 
and centrifuged at 13000 rpm for 30 min. at 4oC.  The pellet was resuspended in 
Rapidgest (Waters, Milford, Massachusetts) containing trypsin and 50 mM 
sodium bicarbonate, incubated overnight at 37oC, and subsequently injected into 
a liquid chromatography column connected to a tandem mass spectrometer (LC-
MS/MS).  The resulting spectra, excluding the peaks from human keratin and 
bovine trypsin, were analyzed using the Mascot search engine.97  Search 
parameters were limited to the Rattus taxonomy (66908 sequences) and with the 
trioxidation of cysteine and oxidation of methionines as a variable modification.  
Peptide mass tolerances were set to 2 Daltons, fragment mass tolerances were 
set to 1 Dalton, and two missed cleavages were accepted.  Searches were 
performed using the non-redundant proteins at the National Center for 
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Biotechnology Information (NCBInr version 20100908 (11756863 sequences, 
4014994744 residues)).  Protein hits were scored using standard Mascot scoring 
and a Mascot score greater than 30 was regarded as significant (p<0.05).  An 
exponentially modified Protein Abundance Index (emPAI) score for each protein 
hit was also determined by the software.  The emPAI score is roughly correlated 
to protein concentration and can be used for relative quantitation.98  Manual 
analysis of the protein hit list was used to identify the ECM proteins present 
within each group. 
 
4.2.7 Calcium and Phosphate Assays 
Three constructs from each group were rinsed twice with sterile Millipore-filtered 
water, and 1 mL of 1 N acetic acid was added to each construct.  The constructs 
were minced with microscissors and placed on a shaker table at room 
temperature for 1 day at 75 rpm to dissolve any mineral salts present in the 
construct.  Three femora were fragmented with a mortar and pestle and placed 
into 1 mL of 12 N hydrochloric acid overnight at room temperature.  The calcium 
content of the constructs and bones were determined as previously described, 
with each sample measured in triplicate.18  The phosphate content of the 
constructs and bones was measured in triplicate and was determined by 
following the protocol supplied by the manufacturer of the assay kit (R & D 
Systems, Minneapolis, MN). 
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4.2.8 SEM and EDX Analysis 
Femora fragments and one construct from each group were fixed with 2.5% 
glutaraldehyde solution (Sigma-Aldrich) at room temperature for 45 min., dried 
using an ethanol gradient, frozen, and then lyophilized.  The bone fragments and 
constructs were sputter coated with gold prior to imaging with an FEI Quanta 400 
ESEM FEG (FEI Company, Hillsboro, OR) at 1000x magnification in the center of 
each sample.  Additionally, each specimen was scanned at 1000x magnification 
at three different spots using an EDX (EDAX Inc., Mahwah, NJ) integrated with 
the SEM until the relative intensities of the peaks became stable, and the 
resulting peaks were identified using the EDAX Genesis software package 
(EDAX Inc.).  Each element identified was quantified into an atomic percentage 
by the EDAX software, and the Ca:P ratio was determined by dividing the 
calcium percentage by the phosphorous percentage. 
 
4.2.9 XRD Analysis 
The mineral pellets for each group, isolated during the protein extraction step, 
were washed twice with Millipore-filtered water to remove soluble salts remaining 
in the pellet and subsequently air dried.  Femora fragments were crushed into a 
fine powder using a ceramic mill.  The powder from each group was placed on a 
zero background wafer (Rigaku, The Woodlands, TX) and analyzed using a 
D/Max XRD (Rigaku).  The powders were scanned for a fixed time of 12 seconds 
per step from 10o to 60o using a 2 mm divergent slit, a step size of 0.10o, and a 
variable receiving slit.  Spectrum identification was performed using Jade 9 
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software (MDI, Livermore, CA) and matched with crystals from the PDF 4 
database provided with the Jade 9 software using a chemistry filter for 
compounds containing only calcium, phosphorous, oxygen, and carbon.  The 
spectra were matched according to best figure of merit and a 2θ offset between -
0.100 and 0.100, and any peaks not accounted for by the first identification 
procedure were matched with the same database.  The percent crystallinity was 
determined by adding a linear background, manually identifying peaks, and fitting 
the peak profiles to the spectra until the residual stabilized.  This procedure was 
repeated three times and the resulting crystallinities were averaged. 
 
4.2.10 Statistical Analysis 
Results are presented as means ± standard deviations.  Statistical significance 
for the calcium and phosphate assay data was determined using Tukey’s 
Honestly Significant Differences test with a 95% or a 99% confidence interval 
with JMP IN 5.1 software (SAS Institute Inc., Cary, NC). 
 
4.3 Results 
4.3.1 LC-MS/MS Analysis 
No ECM proteins were detected by LC-MS/MS analysis for the PCL day 8 
constructs (Table 4.1).  The PCL day 12 constructs were found to contain 
fibronectin, a cell binding protein that forms a fibrillar network extending between 
adjacent cells; fibulin-1, a protein that binds to fibronectin and regulates its fibril 
diameter; procollagen 6, a cell binding protein that interacts with fibronectin and 
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collagen 1 and is suggested to anchor the basement membrane to underlying 
connective tissue; periostin, a protein that plays a role in the formation of 
collagen cross-links, interacts with fibronectin, and directly binds to bone 
morphogenic protein-1 (BMP-1); collagen 1, the main structural protein of bone; 
and MMP-2, a gelatinase that may play a role in angiogenesis by remodeling the 
ECM.11,170-174  The emPAI score for fibronectin was higher than for collagen 1, 
periostin, procollagen 6, and MMP-2 in the PCL day 12 constructs, and no score 
was reported for fibulin-1.   
 
The PCL day 16 constructs were found to retain all proteins observed in the PCL 
day 12 constructs, with the exception of fibulin-1, based on LC-MS/MS analysis.  
Three additional proteins were found within the constructs, including: high-
temperature requirement A serine peptidase 1 (HtrA1), a peptidase that 
degrades fibronectin and inhibits transforming growth factor-β (TGF-β)/BMP 
signaling; thrombospondin 2 (TSP-2), a protein that inhibits angiogenesis and 
binds to fibronectin; and pigment epithelium-derived factor (PEDF), another 
protein that inhibits angiogenesis, expressed during early bone development, and 
may counteract vascular endothelial growth factor A (VEGF-A).175-177  The emPAI 
score was higher for fibronectin than for all other proteins detected in the PCL 
day 16 constructs, with the exception of TSP-2, which reported no score. 
 
The PCL/ECM 0 constructs were found by LC-MS/MS to contain fibronectin, 
fibulin-1, HtrA1, collagen 1, procollagen 6, and thrombospondin 1 (TSP-1), a 
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protein that inhibits angiogenesis, activates the TGFβ family of proteins, and 
binds to glycosaminoglycans.178  The emPAI score for HtrA1 was higher than for 
all other proteins detected in the PCL/ECM 0 constructs. 
 
LC-MS/MS detected the presence of two ECM proteins in the PCL/ECM day 4 
constructs: osteopontin, a calcium-binding glycoprotein that binds cells and 
preferentially accumulates at ECM discontinuities including healing bone 
surfaces and at cell-matrix interfaces, such as on activated bone surfaces; and 
secreted phosphoprotein 2, 24 kDa (SPP-24 or SPP-2), a protein that binds 
BMP-2 and hydroxyapatite, and regulates the bioavailability of BMP-2.179,180  
Within these constructs, osteopontin presented a higher emPAI score than SPP-
24. 
 
LC-MS/MS analysis of the PCL/ECM day 8 constructs detected periostin at a 
higher level than procollagen 6 (as reflected by the emPAI scores), while 
osteopontin and SPP-24 were no longer present.  The PCL/ECM day 16 
constructs contained procollagen 6, fibronectin, and PEDF along with fibulin-1 
and alkaline phosphatase, an enzyme that hydrolyzes pyrophosphates and is an 
early marker of osteogenic differentiation.181   The emPAI scores for procollagen 
6 and fibulin-1 were higher than the scores for alkaline phosphatase, PEDF, and 
fibronectin.   
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4.3.2 Calcium and Phosphate Assays 
The number of moles of calcium ions and phosphate ions present in the 
constructs was found to increase with increasing culture durations (Figure 4.1).  
The PCL day 8 and PCL day 12 constructs demonstrated a significantly lower 
(p<0.05) amount of calcium ions present as compared to PCL/ECM day 16 
constructs.  The PCL day 8 constructs also exhibited a significantly lower 
(p<0.05) amount of calcium ions as compared to the PCL/ECM day 8 constructs.  
In addition, the PCL day 8 constructs were observed to have a significantly lower 
(p<0.05) amount of phosphate ions as compared to PCL/ECM day 16 constructs.  
The ratio of calcium to phosphorous (Ca:P) as determined by the calcium and 
phosphate assays for each group is illustrated in Table 4.2.  The Ca:P ratio for 
PCL day 12 constructs was significantly lower (p<0.01) than that of mature bone, 
when using the calcium and phosphate assay results.  Additionally, the Ca:P 
ratio for the PCL day 16, PCL/ECM day 4, PCL/ECM day 8, and PCL/ECM day 
16 constructs were significantly lower (p<0.05) than that of mature bone, when 
using the calcium and phosphate assay results. 
 
4.3.3 Scanning Electron Microscopy 
Nodules were found by SEM to be present on the constructs, and the abundance 
of nodules was found qualitatively to increase with increasing culture durations 
(Figure 4.2).  PCL day 8 constructs demonstrated sparse nodules with a matrix 
coating on the electrospun PCL, whereas PCL day 16 constructs showed large 
amounts of nodules present on top of the matrix coating.  PCL/ECM day 8 and 
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PCL/ECM day 16 constructs demonstrated a full coating of nodules on the 
surface. 
 
4.3.4 Electron Dispersive X-ray Spectroscopy 
The EDX spectrum in Figure 4.3 illustrates that the PCL day 16 constructs had 
carbon, oxygen, phosphorous, calcium and gold atoms present.  The gold atoms 
were an artifact related to the gold coating necessary for SEM imaging.  The ratio 
of calcium to phosphorous (Ca:P), as calculated from the atomic percentage data 
obtained from the EDAX software in the EDX analysis, of the entire scanned 
region seen in the SEM micrographs in Figure 4.2 is presented in Table 4.2. 
 
4.3.5 X-Ray Diffraction Analysis 
The XRD spectra of the various groups are illustrated in Figure 4.4.  As the ECM 
matured for each of the PCL and PCL/ECM based constructs, there was an 
increase in intensity of the peaks at 2θ angles of 26o, 28o, 32o, 40o, and 50o and a 
slight decrease of the peak at 21o.  The analysis demonstrated that all constructs 
had a major phase composed of hydroxyapatite (HAp) and a minor phase 
composed of tricalcium phosphate (TCP), except for the PCL day 8 constructs 
(Table 4.3).  Each construct demonstrated crystallinities over 80%, with the 
exception of the PCL day 8 construct. The figures of merit for all groups were 
large, which indicated a poor fit of the spectra of the mineral content of the 
constructs to the database values for pure HAp and TCP.  However, the 2θ 
offset, which represents how much the software had to shift the peaks to match 
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the HAp and TCP spectra within the database, was nil for some constructs, 
including PCL day 12 HAp, PCL/ECM day 4 HAp, PCL/ECM day 8 TCP, and 
mature bone HAp.  The software was unable to match the minerals from the PCL 
day 8 constructs to any of the compounds in the database that contained the 
elements found by EDX analysis and was unable to determine the percent 
crystallinity. 
 
4.4 Discussion 
Prior analyses of constructs developed within our laboratory have demonstrated 
that the in vitro-generated ECM deposited by MSCs onto PCL and titanium 
constructs promoted osteogenic differentiation of MSCs in vitro and that the 
titanium-based constructs comprised collagens, glycosaminoglycans, and a 
calcium-based mineral.18,64  The goal of this study was to determine whether the 
ECM deposited by MSCs within the constructs cultured under flow perfusion 
conditions replicates the proteins and minerals found in mature bone and if there 
is a temporal effect in the deposition of these components during in vitro culture. 
 
For the PCL day 8 constructs no secreted proteins were detected by LC-MS/MS.  
However, an extracellular matrix coating appeared to be present via SEM for 
these constructs.  The lack of detected protein via LC-MS/MS may reflect that the 
amount of protein extracted from the constructs was below the threshold for 
detection. 
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For the PCL day 12 constructs, a high abundance of fibronectin was observed, 
which may facilitate cell adhesion to the PCL scaffold.  Further, fibulin-1 was 
detected within the PCL day 12 constructs.  Fibulin-1 is known to regulate the 
fibril diameter of fibronectin and may reflect that the fibronectin was in a fibrillar 
form.174  However, an emPAI score for fibulin-1 was not generated, which 
suggests that the protein was a weak hit and may not be present within the 
constructs.  The presence of secreted collagen 1 and periostin within the 
constructs suggests the production of a collagenous network by the cells, as 
periostin plays a role in cross-linking collagen.172  Also, the presence of 
procollagen 6 in similar quantities to collagen 1 may reflect that it was deposited 
to assist in anchoring the collagen 1 network to the deposited fibronectin within 
the construct.  MMP-2 was observed in similar quantities to collagen 1, which 
may suggest that the MSCs secreted the protease so that it would be able to 
degrade any malformed collagen that may have been deposited. 
 
For the PCL day 16 constructs, high levels of fibronectin remained present within 
the constructs.  A slight decrease in procollagen 6 as compared to the PCL day 
12 constructs was also observed.  However, there were similar amounts of 
collagen 1, MMP-2, and periostin in PCL day 12 and PCL day 16 constructs.  
The loss of fibulin-1 may be explained by the appearance of TSP-2, which binds 
to fibronectin as well.  However, similar to fibulin-1, the emPAI score was not 
given for TSP-2 and thus it may not be present within the constructs.  The 
decrease in fibronectin may suggest that HtrA1 degraded some of the deposited 
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fibronectin.  A decrease in procollagen 6 may also be linked to the decrease in 
fibronectin, since it is a linker protein between collagen 1 and fibronectin.  The 
appearance of PEDF and TSP-2 may suggest that the MSCs were beginning the 
mineralization process of the constructs.  PEDF and TSP-2 are known to bind to 
collagen 1, found in developing bone matrix, and PEDF is secreted at high levels 
by osteoblasts, while TSP-2 is secreted by MSCs undergoing osteogenic 
differentiation.176,182-184  In addition, TSP-2 and PEDF are anti-angiogenic factors, 
thus their presence may imply that the MSCs are regulating an angiogenic factor, 
such as VEGF-A or bFGF.   
 
With respect to the PCL/ECM day 4 constructs, both osteopontin and SPP-24 
were observed with high emPAI scores.  SPP-24 is found at high levels in the 
bones of neonates and may be important in neonatal skeletal development and 
the acquisition of peak bone mass.179  The presence of both osteopontin and 
SPP-24 may reflect that the reseeded MSCs recognized the PCL/ECM scaffold 
as a bony surface and were depositing proteins that encouraged cell adhesion to 
the surface.   
 
For the PCL/ECM day 8 constructs, the disappearance of both osteopontin and 
SPP-24 may imply that the proteins have performed their function of recruiting 
more cells to the damaged bony surface and were not necessary for further 
development.  With the deposition of procollagen 6 and periostin, it appears that 
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the MSCs were developing the pre-requisite matrix for further mineralization of 
the constructs. 
 
Regarding the PCL/ECM day 16 constructs, the presence of procollagen 6, 
fibulin-1, and fibronectin suggests that the MSCs are further developing the 
extracellular matrix.  The disappearance of periostin may be due to batch 
differences between the MSCs used for generation of the scaffold.  The secretion 
of alkaline phosphatase indicates that the MSCs were undergoing osteogenic 
differentiation inducing further mineralization of the constructs.  The deposition of 
PEDF also signifies that the MSCs had fully differentiated into osteoblasts. 
 
Of interest is the fact that there were no similar proteins observed between the 
PCL/ECM day 4 and either the PCL day 12 or the PCL/ECM 0 constructs.  This 
is surprising since the PCL/ECM day 4 constructs were derived from MSCs 
cultured for 4 days on sterilized, dried, and decellularized PCL day 12 constructs 
(i.e., PCL/ECM 0 constructs).  However, the PCL day 12 constructs were not 
sterilized prior to analysis.  Consequently, the PCL/ECM 0 constructs provide a 
baseline for comparison, as they were prepared in the same manner as the PCL 
day 12 constructs, with the exception that the PCL/ECM 0 constructs were 
sterilized via exposure to ethylene oxide prior to matrix analysis. 
 
Similar proteins were found to be present in the PCL 12 and PCL/ECM 0 
constructs, based on LC-MS/MS analysis, as expected.  Specifically, fibronectin, 
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fibulin-1, collagen 1, and procollagen 6 were detected in both constructs.  
However, HtrA1 and thrombospondin 1 were measured in the PCL/ECM 0 
construct, while MMP-2 and periostin were not detected.  The difference may 
reflect slight variability between the batches of MSCs used to generate the 
constructs or limitations of the LC-MS/MS technique itself, but it does not appear 
to indicate a detrimental effect of the sterilization procedure on the matrix, as 
characterized by LC-MS/MS.  Interestingly, the PCL/ECM 4 scaffolds did not 
retain any of the proteins detected in the PCL/ECM 0 scaffolds.  The MSCs 
seeded onto the PCL/ECM 0 constructs may have degraded the proteins 
present, which by day 4 of culture (PCL/ECM day 4) could have been below the 
threshold level for detection. 
 
The protein compositions of the constructs as measured by LC-MS/MS in the 
present study did not fully resemble the known composition of mature or 
developing bone.  However, the constructs began to consist of several of the 
mature bone proteins as culture duration increased.  Mature and developing 
bone is composed of collagen 1, fibronectin, glycosaminoglycan substituted 
proteoglycans such as decorin and biglycan, MMPs such as MMP-2 and MMP-9, 
and growth factors such as BMP-2, VEGF, and basic fibroblast growth factor 
(bFGF).11  From our prior studies, collagen 1 and some glycosaminoglycans 
(GAGs) were expected.64,169  However, no GAG substituted proteoglycans were 
detected in any of the constructs and this may be due to the amount of 
proteoglycans extracted being below the threshold of LC-MS/MS detection.  
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Alternatively, the lack of detected proteoglycans and GAGs may be due to the 
lack of deglycosylation and chondroitinase treatment of the protein extract.   
 
The appearance of growth factors was expected within the constructs, 
nevertheless, only the anti-angiogenic growth factor PEDF was reported.  The 
lack of expression of VEGF-A is not unexpected due to its high diffusivity and its 
lack in ability to bind to ECM molecules when it is present in its shortest splice 
form.185  As well, bFGF has a short half-life in vivo and washes easily away if it is 
not bound to heparan sulfate.186,187  Furthermore, the lack of VEGF-A or bFGF 
may be due to a low amount of it being secreted by the MSCs, thus it would not 
be detected by the LC-MS/MS technique.  However, the lack of detection of 
TGFβ-1 and BMP-2 was unexpected.  Both TGFβ-1 and BMP-2 encourage bone 
formation and may be expected to be secreted by the MSCs, especially in the 
PCL/ECM based scaffolds since they resemble bone to a higher degree than the 
PCL scaffolds.139  However, these growth factors, although absent in the present 
analyses, may appear at longer culture durations or the extracted amount may 
be below the detection level of the LC-MS/MS. Indeed, previous studies 
employing immunohistochemistry analysis of matrix produced by MSCs cultured 
under flow perfusion conditions on scaffolds comprising a blend of starch and 
PCL were found to contain several bone-related growth factors, including TGFβ-
1, fibroblast growth fator-2, VEGF and BMP-2.188  As none of these growth 
factors were detected by LC-MS/MS in the present study, the sensitivity of the 
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LC-MS/MS technique may not have been sufficient for full characterization of the 
protein component of ECM constructs of the dimensions explored in this study.   
 
The mineral component of the constructs was demonstrated to contain Ca2+ and 
PO43- ions, and the amount of these ions increased over time.  The increase in 
Ca2+ is similar to what has been previously observed in bioreactor studies using 
titanium and PCL fiber mesh scaffolds in our laboratory.18,64,67  It can also be 
seen through the Ca:P ratio that the concentration of the Ca2+ and PO43- ions 
were very similar to each other at each culture period, excluding the case of the 
PCL day 8 constructs.  Comparing to the ratio found in mature bone, it can be 
seen that the ratio was almost double what is found in the constructs.  The 
difference may be accounted for by the method of generating the constructs, 
which may leave DNA fragments and cell debris throughout the constructs.  
These cellular remnants are potential sources of PO43-, and may skew the Ca:P 
ratio towards a lower value. 
 
The EDX spectrum in Figure 4.3 demonstrated that the constructs were 
composed of carbon, oxygen, phosphorous, and calcium.  Comparing the EDX 
spectrum from PCL day 8 constructs to PCL day 16 constructs (data not shown), 
there was a noticeably lower intensity for the calcium and phosphorous peaks in 
the PCL day 8 constructs.  Combined with a lower visible number of nodules in 
the SEM micrograph of the PCL day 8 construct, this implies that the nodules are 
the main source of the calcium and phosphorous peaks seen in the EDX spectra 
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of all the constructs.  However, in the absence of a more detailed analysis, the 
nodules cannot be irreproachably shown to be the mineral deposits found within 
the constructs. 
 
Table 4.2 shows the calculated Ca:P ratio from the EDS spectra and 
demonstrates that the Ca:P ratio of all the constructs, excluding the PCL day 8 
and PCL/ECM day 8 constructs, was similar to mature bone.  From the ratios, it 
can be seen that the minerals are not pure HAp, which has a ratio of 1.67.  
However, the HAp present in bone has many substitutes including Na+, Mg2+, 
HPO42-, CO32-, OH-, Cl-, and F-, thus an observed ratio within the range of 1.41 to 
1.99 would not be unexpected.189  The observed Ca:P ratios in the constructs 
and bone also suggest that the minerals could be amorphous calcium phosphate 
(ACP), due to the varied stoichiometry of ACP, octacalcium phosphate (OCP), or 
a mixture of several mineral phases.189,190   However, combining the Ca:P ratio 
with the analysis of the XRD spectra suggests that the minerals were a mixture of 
two phases, composed mainly of HAp with a minor phase of TCP present, with 
the exception of the PCL day 8 constructs.   
 
Nevertheless, the analysis of the minerals may have been affected by the 
decellularization procedure and isolation of the mineral pellets from the 
constructs.  The decellularization procedure requires multiple freeze and thaw 
steps in water and a drying step, while the isolation of the mineral pellets 
required a water wash step to remove any remnant protein extract solution and a 
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subsequent drying step.  The water wash and drying steps may have dissolved 
amorphous mineral components or altered the crystallinity of the minerals.  
However, all samples for the various mineral analyses were treated in the same 
fashion, thus any changes that may have occurred would be consistent across 
samples. 
 
The peak locations and breadths visible in the XRD spectra for PCL day 16 and 
PCL/ECM day 16 constructs and the Ca:P ratios derived from the EDX spectra of 
both of these constructs were similar to that of the mature bone.  The spectra of 
both of these constructs developed broad and minor peaks at 28o, 40o, and 50o, 
similar to that seen in the spectrum of mature bone and, with the increase in 
intensity of the major peaks at 26o and 32o as the constructs increased in culture 
duration, suggests that the mineral composition is approaching that of mature 
bone.  Encouragingly, the figure of merits of each mineral type in the construct 
started to approach 0, which indicates that the minerals were beginning to 
resemble pure hydroxyapatite and tricalcium phosphate.  In addition, there was a 
trend of increasing crystallinity that approached that of mature bone as the 
culture duration increased. 
 
It can also be observed that the spectrum of PCL day 16 constructs rather than 
that of PCL/ECM day 4 constructs had a greater resemblance to mature bone, 
although both constructs were cultured for the same length of time.  This may be 
because the scaffolding for the PCL/ECM based constructs was based on the 
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PCL day 12 constructs.  As can be seen, the spectrum of the PCL/ECM day 4 
constructs appears to resemble that of the PCL day 12 constructs.  The 
reseeding procedure covers the surface of the decellularized PCL day 12 
constructs with MSCs, and osteopontin deposited by the MSCs may have 
prevented the maturation of the previously deposited minerals.  However, the 
maturation of the minerals may have also been affected by the decellularization 
procedure or by the reseeding of the pre-differentiated MSCs.  Only by day 16 of 
culture for the PCL/ECM constructs does the spectrum start to resemble that of 
mature bone. 
 
However, the nodules on the surface of the constructs seen in Figure 4.2 do not 
resemble the mineralized surface of mature bone.  Mature bone is known to have 
a highly ordered surface composed of plate-like crystals of nano-crystalline HAp 
with many ion substitutes.189,191-193  Even the longest culture period constructs, 
PCL day 16 and PCL/ECM day 16, which have some nodules that look needle-
like, do not resemble mature bone (SEM micrograph not shown).  Nevertheless, 
the surface of the constructs may change at a later point, due to the crystals 
growing larger and fusing together or through an organization of the ECM. 
 
4.5 Conclusions 
Overall, this study demonstrates that MSCs seeded upon PCL-based constructs 
and cultured under engineered conditions with a flow perfusion bioreactor deposit 
cell adhesive, structural, remodeling, and regulatory proteins as well as 
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hydroxyapatite minerals found in developing and mature bone.  The protein 
composition of the constructs as they are cultured over time revealed that the 
MSCs deposited cellular adhesion proteins, such as fibronectin, at short culture 
durations, while they deposited matrix remodeling and regulatory proteins, such 
as MMP-2 and PEDF, at long culture durations.  The constructs were seen to 
contain the major components of mature bone, collagen 1 and hydroxyapatite.  
The constructs also contain fibril-regulating proteins that help to organize 
collagen 1 and fibronectin, and matrix remodeling proteins, thus the ECM has 
started to resemble that of mature bone.  However, only one anti-angiogenic 
growth factor and no glycosaminoglycan-substituted proteoglycans were 
identified.  Further analysis will be needed to determine the effect that ECM 
maturity has on bone formation and regeneration in vivo.   
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Table 4.1:  The proteins present within each type of construct as found by LC-
MS/MS.  The best match for each protein and the associated Mascot score are 
presented.  The emPAI score gives a rough estimate of the quantity of the 
protein within the constructs. 
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Table 4.2:  The ratio of calcium to phosphorous present on the constructs as 
determined by the calcium and phosphate assays and by EDX analysis.  The 
Ca:P ratio is indicative of the type of calcium phosphate present, with pure 
hydroxyapatite having a Ca:P ratio of 1.67.  Data are expressed as means ± 
standard deviation for n=3 for the Ca and PO4 assay.  EDX data are expressed 
as means ± standard deviation for three separate spots analyzed on a single 
sample. 
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Table 4.3:  The crystallinity and figure of merit for the fit of each mineral type 
present as determined by XRD.  The 2θ offset represents the shift (in degrees) 
required by the software to match the respective spectra to the HAp or TCP 
peaks within the PDF 4 database.  The (M) represents a major phase and the 
(m) represents a minor phase.  Data are expressed as means ± standard 
deviation for three manual fittings of the spectra obtained from a single sample 
comprising the combined mineral component of six constructs. 
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Figure 4.1:  The amount of calcium and phosphate ions present in each scaffold 
at different stages of the ECM maturity.  The * symbol represents a significant 
difference of p<0.05 to the PCL/ECM day 8 group and the # symbol represents a 
significant difference of p<0.05 to the PCL/ECM day 16 group.  Data are 
expressed as means ± standard deviation for n=3. 
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Figure 4.2:  SEM micrographs of the top of the flow generated acellular 
constructs. A) PCL day 8, B) PCL day 12, C) PCL day 16, D) PCL/ECM day 4, E) 
PCL/ECM day 8, F) PCL/ECM day 16.  As culture duration increases, there is an 
appearance and growth of mineral nodules on the surface. 
99 
 
 
 
Figure 4.3:  A representative EDX spectrum of the constructs.  EDX analysis 
demonstrates the presence of carbon, oxygen, calcium, phosphorous, and gold 
on the surface of the constructs.  The presence of gold is due to its use in coating 
the constructs for SEM imaging. 
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Figure 4.4:  XRD spectra of the constructs.  The PCL day 8 construct 
demonstrates minor broad peaks within the scan range.  All other constructs 
demonstrate broad peaks at 26o and 32o.  Peaks at 28o, 40o, and 50o can be 
seen in PCL day 16 and PCL/ECM day 16 constructs, similar to those seen in 
mature bone. 
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CHAPTER 5 
 
Osteogenic Differentiation of Mesenchymal Stem Cells on Demineralized 
and Devitalized Poly(ε-caprolactone) and Extracellular Matrix Hybrid 
Constructs 
 
Abstract 
 
Devitalization and demineralization processing of polymer and extracellular 
matrix (ECM) hybrid constructs was explored for the effect on the retention of 
ECM components and construct osteogenicity.  Hybrid constructs were 
generated by seeding osteogenically pre-differentiated rat mesenchymal stem 
cells (MSCs) onto electrospun poly(ε-caprolactone) fiber mesh scaffolds and 
culturing in osteogenic medium for 12 or 16 days within a flow perfusion 
bioreactor to create an ECM coating.  The constructs were either untreated, 
devitalized (using a freeze-thaw or a detergent technique), or devitalized and 
demineralized, and subsequently characterized for DNA, glycosaminoglycan 
(GAG), collagen, and calcium content.  The osteogenicity of each construct was 
investigated by culturing MSCs on the hybrid constructs within a flow perfusion 
bioreactor for 4, 8 and 12 days in osteogenic medium.  Cellular proliferation was 
determined by DNA assay, while osteogenic differentiation of MSCs was 
determined by the alkaline phosphatase activity and calcium assays.  Distribution 
of the ECM throughout the processed and MSC-seeded constructs was 
visualized by scanning electron microscopy and histological staining.  This study 
establishes that the freeze-thaw devitalization method disturbs the ECM coating  
 
__________________________ 
* This manuscript was prepared as presented for submission to Journal of Biomedical Materials 
Research Part A.  The Supplementary Figures are included as well. 
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the least and provides beneficial void spaces in the surface ECM coating,  
allowing cells access to the interior of the construct. 
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5.1 Introduction 
Craniofacial defects caused by trauma, disease, and congenital deformity can be 
clinically repaired using the current gold standard, autologous bone, if the defect 
is of limited size.194  However, some patients have defects encompassing a large 
volume which cannot be adequately repaired using their own bone tissue.  To 
address this issue, allogeneic bone and demineralized bone matrix (DBM) have 
been employed to provide the necessary amount of graft material to repair large 
defects.195  However, these graft materials have had limited success at bone 
regeneration and integration with the surrounding bone at the defect site.122,196,197  
This limited success may be due to the devitalization and sterilization processes 
required to generate allogeneic bone and DBM.  Both allogeneic bone and DBM, 
prior to being used as bone graft material, are rendered acellular and sterile 
although an additional morselization and demineralization step is required for 
DBM.120  These processing steps have been shown to reduce the osteogenic 
and osteoinductive properties of the graft materials as compared to autologous 
bone.194,197   
 
The goal of tissue engineering is to create an osteogenic and osteoinductive 
construct that regenerates bone for use in bone defect repair.  Our laboratory has 
developed a cell-generated extracellular matrix (ECM) coated polymer construct 
as a potential bone regenerative material.18,143  Previous investigation into these 
constructs has determined that they are comprised of collagen type I and 
hydroxyapatite, along with other important cell-adhesive and regulatory proteins 
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that are present within native bone.76  In addition, pre-differentiated 
mesenchymal stem cells (MSCs) cultured on these constructs under static 
conditions and in medium lacking osteogenic supplements have displayed 
increased osteogenic differentiation when compared to MSCs cultured on only 
the polymer material.18  However, prior to the seeding of the MSCs, the 
constructs underwent a devitalization and sterilization process.18,76  Therefore, 
analogous to allogeneic bone grafts and DBM, these processed constructs may 
have a reduced osteogenic and osteoinductive potential as compared to 
untreated constructs.   
 
The devitalization and demineralization techniques employed in this study have 
been adapted from the processing of bone grafts and tissues.198,199  Indeed, 
other cell-generated ECM coated scaffolds have been devitalized using these 
techniques, but there is little investigation into the effects of various devitalization 
methods on the composition of the cell-generated ECM coatings.51,57,200-203  
Accordingly, this study investigates whether these modified bone graft 
processing techniques affect the retention of the ECM components and the 
osteogenic differentiation of MSCs cultured onto these constructs.  Constructs 
were generated by seeding osteogenically pre-differentiated MSCs onto 
electrospun poly(ε-caprolactone) (PCL) and culturing them within a flow perfusion 
bioreactor for 12 days or 16 days in osteogenic medium.  Subsequently, they 
were either i) sterilized, ii) sterilized and devitalized using a freeze-thaw method, 
iii) sterilized and devitalized using a detergent procedure, or iv) sterilized  and 
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devitalized and demineralized using a freeze-thaw method combined with an acid 
treatment.  Each construct was characterized by measuring the amount of DNA, 
glycosaminoglycans (GAGs), collagen, and calcium within each construct to 
determine the extent of loss of biological material due to processing.  Scanning 
electron microscopy (SEM) and histological staining for GAGs, collagen, and 
calcium was also performed to determine the distribution of each component 
within the constructs.  Furthermore, osteogenically pre-differentiated MSCs were 
seeded onto each cell-generated ECM polymer construct and cultured in 
osteogenic medium within a flow perfusion bioreactor for 4, 8, and 12 days.  The 
cellularity and mineralization of the construct, along with the alkaline 
phosphatase (ALP) activity of the MSCs was determined to elucidate the effects 
of processing on the osteogenic differentiation of cultured MSCs within the 
constructs.  Additionally, SEM and histological staining was performed to 
determine ECM distribution throughout the constructs seeded with MSCs. 
 
5.2 Methods and Materials 
5.2.1 Materials 
PCL with an inherent viscosity of 0.68 dL/g was purchased from DURECT 
Corporation (Pelham, AL).  The ethylene oxide was obtained from Andersen 
Sterilizers Inc. (Haw River, NC).  The Fischer 344 rats were purchased from 
Charles River Laboratories (Wilmington, MA).  The α-MEM was obtained from 
Invitrogen (Carlsbad, CA) while the fetal bovine serum was purchased from 
Gemini Bio-Products (West Sacramento, CA).  The PicoGreen assay was 
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purchased from Molecular Probes (Eugene, OR).  The Arsenazo III was 
purchased from Diagnostics Chemicals Limited (P.E.I., Canada). The rest of the 
chemical were purchased from Sigma-Aldrich (St. Louis, MO). 
 
5.2.2 Fabrication of PCL Scaffolds 
The PCL was characterized using gel permeation chromatography and 
polystyrene standards to determine that it had a number average molecular 
weight of 61000 ± 2500 Da and a weight average molecular weight of 88500 ± 
2700 Da.  The PCL was dissolved in a 5:1 (v/v) chloroform:methanol solution at 
18% (w/w) prior to being electrospun as previously described to produce fiber 
mesh mats with a porosity of 87% and an average fiber diameter of 
approximately 10 µm.143  Disc-shaped scaffolds 8 mm in diameter and 
approximately 1 mm thick were prepared from the PCL mats using a biopsy 
punch, then subsequently sterilized by exposure to ethylene oxide for 14 hours, 
and pre-wetted using an ethanol gradient prior to cell seeding. 
 
5.2.3 MSC Isolation 
MSCs were harvested and pooled from the marrow of tibiae and femora of 4 
male Fischer 344 rats (150 – 175 g) as previously described.68  NIH guidelines 
for the care and use of laboratory animals (NIH Publication #85-23 Rev. 1985) 
have been observed.  The MSCs were cultured in complete osteogenic media (α-
MEM, 10% fetal bovine serum, 10 mM β-glycerol-2-phosphate, 10 nM 
dexamethasone, 50 µg/mL ascorbic acid, 50 µg/mL gentamicin, 100 µg/mL 
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ampicillin, and 0.5 µg/mL fungizone) for 7 days to pre-differentiate them along the 
osteogenic pathway.68   
 
5.2.4 MSC Culture on PCL Scaffolds 
Prior to cell seeding, pre-wetted PCL scaffolds (n = 128) were transferred into 
complete osteogenic medium for 2 hours, press-fit into cassettes, and maintained 
briefly in an incubator.  A quarter-million of the isolated MSCs in 200 µL of 
complete osteogenic medium were seeded onto each PCL scaffold, and the 
MSCs were allowed to adhere to the scaffold overnight in the incubator.  
Subsequently, the cassettes containing cell-seeded scaffolds were placed into 
flow perfusion bioreactors with a flow rate of 0.7 mL/min and 200 mL of complete 
osteogenic medium per bioreactor, which was exchanged every 3 days.61  Sixty-
four constructs each were removed from the bioreactors at day 12 (PCL/ECM 12) 
and day 16 (PCL/ECM 16).   
 
5.2.5 Construct Processing 
The PCL/ECM 12 and PCL/ECM 16 constructs were processed using four 
different methods (n = 16) and is described in Table 5.1.  Constructs from each 
processed group (n = 3) was digested using Proteinase K to generate a sample 
solution and analyzed by the DNA, GAG, hydroxyproline, and calcium assays.  
One additional construct was fixed in 2.5% (v/v) glutaraldehyde for 45 minutes 
and cut in half for use in histological analysis and SEM. 
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5.2.6 Seeding of the ECM-Coated Constructs with MSCs 
Constructs from each of the groups listed in Table 5.1 (n = 12) were treated and 
seeded with MSCs in a similar manner as previously described in the MSC 
culture on PCL scaffolds section.  Three constructs were removed from each 
group after 4, 8, and 12 days and placed in Millipore water.  Each culture period 
underwent a repeated freeze-thaw procedure to generate a sample solution, 
which was later analyzed by the DNA, ALP, and calcium assays.  To determine 
the calcium amount, a volume of 1 N acetic acid equal to the volume of solution 
present in each sample tube was added to each sample solution and construct.  
The resulting 0.5 N acetic acid/sample solution was placed on a shaker table for 
1 day at 100 rpm to dissolve calcium present in the construct.  One construct was 
removed for each group at each culture period, fixed in 2.5% (v/v) glutaraldehyde 
for 45 minutes, cut in half, and retained for histological analysis and SEM. 
 
5.2.7 Proteinase K Digestion 
Proteinase K solution was made by adding 100 mg Proteinase K into 100 mL of 
Pepstatin A buffer and placing the solution within a 56oC water bath for 2 
hours.169  Constructs from each of the processed groups (n = 3) were individually 
placed into 1 mL of Proteinase K solution and placed into a 56oC water bath for 
16 hours.  Afterwards, the constructs and solution underwent 3 cycles of freezing 
and thawing followed by 10 minutes of ultrasonication. 
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5.2.8 Biochemical Assays 
The amount of DNA present within the constructs was determined with the 
PicoGreen assay kit which uses an excitation at 480 nm and the emission was 
measured at 520 nm as previously described.169  The amount of GAGs within 
each construct was determined with the 1,9-dimethyl-methylene blue (DMMB) 
assay and measured at 520 nm as previously described.169  The amount of 
collagen within each construct was determined with the hydroxyproline assay 
and measured at 570 nm as previously described.169  The measured 
hydroxyproline amounts were converted to collagen amounts by using a 
hydroxyproline to collagen ratio of 1:10.204  The calcium amount was determined 
by the Arsenazo III kit and measured at 650 nm as previously described.18,205  
The ALP activity was measured using phosphatase substrate capsules and 
measured at 405 nm as previously described.18   
 
5.2.9 Scanning Electron Microscopy 
After glutaraldehyde fixation, half of a construct was dehydrated in a 
gradient ethanol series, air dried in a laminar air flow cell culture hood, 
lyophilized, and sputter coated with 20 nm of gold prior to imaging.  Each 
construct was imaged using a FEI Quanta 400 ESEM FEG (FEI Company) at a 
magnification of 250 in the center of each construct. 
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5.2.10 Histological Stains 
Sectioning of the processed constructs prior to seeding was performed by 
placing half of a construct into Histoprep overnight, followed by embedding and 
freezing them into blocks at -20oC.  The blocks were sectioned into 5 µm 
sections that were placed onto 4X UV adhesive slides (Electron Microscope 
Sciences) kept at -20oC and adhered to the slide via a brief exposure to 345 nm 
UV light prior to defrosting of the slide at room temperature.  Safranin O, 
picrosirius red, and alizarin red stains were performed on each of these 
sectioned constructs.206-208  For the sectioning of the MSC-seeded constructs, 
half of a construct was placed into Histoprep over night, embedded, and frozen 
into blocks at -20oC.  The blocks were sectioned into 5 µm sections that were 
adhered to super frost plus slides (VWR) and placed on a slide warmer set for 
45oC for 1 day.  Hematoxylin and eosin staining was performed on each of these 
sections.209 
 
5.2.11 Statistical Analysis 
Results are presented as means ± standard deviations. Statistical 
significance between all constructs was determined using Tukey's Honestly 
Significant Differences test with 95% confidence interval using JMP 9 software 
(SAS Institute). 
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5.3 Results 
5.3.1 Amount of DNA, GAGs, Collagen, and Calcium within ECM-Coated 
Constructs 
As can be seen in Figure 5.1, the EO 12 and EO 16 constructs, contained 
significantly more (p<0.05) DNA as compared to their respective FT, Tri, and dM 
constructs.  The processed constructs with the same ECM maturity contained 
similar amount of DNA to each other.  The processed PCL/ECM 16 constructs 
contained significantly more (p<0.05) DNA than the processed PCL/ECM 12 
constructs.  Figure 5.2 demonstrates that there was no significant difference in 
GAG amounts between EO 12 and EO 16 as compared to their respective FT, 
Tri, and dM constructs.  However, there was a significant difference (p<0.05) 
between the amounts of GAGs present within the PCL/ECM 16 constructs as 
compared to their respective PCL/ECM 12 constructs.  As illustrated in Figure 
5.3, there was no significant difference in the amount of collagen contained within 
each construct between 12 and EO 16 as compared to their respective FT, Tri, 
and dM constructs.  However, there was a significant difference (p<0.05) 
between the amounts of collagen contained within the PCL/ECM 16 constructs 
and their respective PCL/ECM 12 constructs with the exception of the FT 12 and 
FT 16 constructs.  Figure 5.4 reveals that there was no significant difference 
between the calcium amount within the processed constructs as compared to the 
sterilized constructs, EO 12 and EO 16.  Nevertheless, there was a trend of lower 
amounts of calcium contained in the FT 12 and dM 12 constructs as compared to 
EO 12.  This was also observed between the dM 16 and EO 16 constructs. 
112 
 
5.3.2 Distribution of ECM Components within the Processed Constructs 
The SEM micrographs in Figure 5.5 show the presence of an ECM coating in the 
EO 12, FT 12, and Tri 12 constructs with minimal amounts of ECM present on 
the dM 12 constructs.  The ECM coating was seen to completely cover the top 
surface of the EO 16, FT 16, and Tri 16 constructs with a minimal presence of 
void spaces.  In contrast, the dM 16 construct contained many void spaces in the 
surface ECM coating. 
 
Figure 5.6i and Figure 5.6ii demonstrate that there was an approximately 100 
micron thick layer of ECM composed of GAGs and collagen at the top of the EO 
12 constructs.  The GAG and collagen layers were approximately 40 microns 
thick in the FT 12 construct, but negligible amounts were present in the Tri 12 
and dM 12 constructs.  The EO 16 construct demonstrated an ECM coating 
throughout the entirety of the construct.  The FT 16 constructs had a 70 micron 
layer of GAGs at the top of the construct with some GAGs present in pockets 
within the interior of the constructs.  Both the Tri 16 and dM 16 constructs 
contained an approximately 20 micron thick layer of GAGs present at the top of 
the constructs.  In addition, the Tri 16 and dM 16 constructs contained an 
approximately 80 micron thick layer of collagen present at the top of each 
construct.  The FT 16 construct was also seen to have collagen present 
throughout the interior of the construct.  Figure 5.6iii shows that the calcium was 
localized in the same area as the collagen component and follows the same 
trends as collagen. 
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5.3.3 Cellularity of the MSC Seeded Processed Constructs 
Figure 5.7 demonstrates that there was no significant difference in cell number in 
the EO 12, FT 12, and dM 12 constructs at day 12.  However, there was a 
significant difference (p < 0.05) in cell number between Tri 12 and EO 12 
constructs at day 12.  The dM 12 constructs had a significantly lower (p<0.05) 
amount of cells present as compared to EO 12, FT 12, and Tri 12 at day 8.  With 
the EO 16, FT 16, and Tri 16 constructs, there was no significant difference in 
cell number at any culture period.  However, the dM 16 constructs had a 
significantly higher (p<0.05) cell number as compared to the EO 16, FT 16, and 
Tri 16 constructs at day 12.  A significantly higher (p<0.05) number of cells was 
seen within EO 12, FT 12, and Tri 12 constructs when compared respectively to 
the EO 16, FT 16, and Tri 16 constructs at day 8.  There was no significant 
difference in the cell number between dM 12 and dM 16 constructs at day 4, day 
8, and day 12. 
 
5.3.4 Alkaline Phosphatase Activity of MSCs Seeded on Processed 
Constructs 
The alkaline phosphatase activity of the MSCs seeded onto the ECM coated 
constructs is illustrated in Figure 5.8.  There was no significant difference 
between the EO 12, FT 12, Tri 12, and dM 12 constructs at day 4, day 8, and day 
12.  However, EO 16 constructs demonstrated a significantly higher (p<0.05) 
ALP activity as compared to the dM 16 constructs at day 8.  Comparing between 
the EO 16, FT 16, and Tri 16 constructs, there was a significant difference 
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(p<0.05) in ALP activity at day 12.  The EO 16 constructs had a significantly 
higher (p<0.05) ALP activity when compared to EO 12 constructs at day 4 and 
day 12.  Similarly, the FT 16 constructs had a significantly higher (p<0.05) ALP 
activity than FT 12 constructs at day 12. 
 
5.3.5 Calcium Deposition of MSC Seeded Processed Constructs 
Figure 5.9 demonstrates that there was no significant difference in calcium 
deposition between the EO 12, FT 12, and Tri 12 constructs at any timepoint.  
However, the Tri 12 constructs had a significantly higher (p<0.05) amount of 
calcium as compared to dM 12 constructs at day 12.  The EO 16 constructs had 
a significantly higher (p<0.05) amount of calcium when compared to either FT 16 
or dM 16 constructs at day 8 and day 12.  Nevertheless, there was no significant 
difference between the EO 12, FT 12, Tri 12, and dM 12 constructs when 
compared respectively to the EO 16, FT 16, Tri 16, and dM 16 constructs at any 
timepoint. 
 
5.3.6 Extracellular Matrix Distribution within MSC Seeded Processed 
Constructs 
The SEM micrographs seen in Figure 5.10 demonstrate an ECM coating on 
each of the constructs, with only the Tri 12 construct lacking a full coating.  In 
addition, the EO 16 construct was seen to have 2 layers of ECM present at the 
top surface of construct. 
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Figure 5.11i demonstrates that the EO 12 constructs had filled with ECM by day 
12.  Additionally, the EO 16 construct was seen to have 2 layers of ECM with the 
top layer approximately 25 microns thick and a bottom layer of ECM present 
throughout the construct by day 12.  Figure 5.11ii shows that the FT 12 
construct produced an approximately 80 micron thick layer of ECM at the top of 
the construct with ECM present in the interior by day 12.  The FT 16 construct 
was seen to have ECM present throughout the construct and an approximately 
160 micron thick layer of ECM present at both the top and bottom of the 
construct at day 4 which increased to approximately 300 microns thick at the top 
and approximately 230 microns thick at the bottom by day 12.  Figure 5.11iii 
demonstrates that both the Tri 12 and Tri 16 constructs produced an 
approximately 100 micron thick layer of ECM at the top of each construct by day 
8, but this disappeared to become an approximately 20 micron thick layer of 
ECM present at the top of the construct by day 12.  Figure 5.11iv shows that the 
dM 12 constructs produced an approximately 120 micron thick layer of ECM at 
the top of the construct by day 8, which increased to approximately 200 microns 
thick by day 12.  The dM 16 constructs demonstrated minor amounts of ECM 
present at both day 4 and day 8, however, by day 12 there is an approximately 
80 micron thick layer of ECM present at the top of the construct. 
 
5.4 Discussion 
The goal of this study was to determine the effects of devitalization and 
demineralization processing of flow perfusion cell-generated ECM constructs on 
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the retention of ECM components and construct osteogenicity.  Characterization 
of the constructs explored the amount and distribution of DNA, GAGs, collagen, 
and calcium, while MSC-seeding of the constructs investigated cellular 
proliferation using DNA amounts and osteogenic differentiation using the well-
established markers of ALP activity and calcium mineralization.148,149 
 
The characterization of the constructs demonstrated that all of the devitalization 
and demineralization techniques were successful in removing cells and calcium 
bearing minerals.  The amount of DNA present in the EO 12 and EO 16 
constructs was significantly higher than those in any of the processed constructs.  
Each processed construct contained similar amounts of DNA, suggesting that no 
devitalization technique was successful in removing all of the nuclear material.  
However, if complete removal of the nuclear material was desired, treatment of 
the constructs with DNases and RNases may potentially be a solution.210,211  
Undetectable levels of calcium were observed for both of the dM 12 and dM 16 
constructs after demineralization demonstrating that the 2% EDTA treatment for 
2 hours is sufficient to remove the calcium deposits.  In addition to the successful 
devitalization and demineralization, no significant difference in the amounts of 
GAGs, collagen, and calcium was measured in each of the FT, Tri, and dM 
constructs when compared to the EO constructs.  This implies that devitalization 
and demineralization had minimal impact on the amount of GAGs, collagen, and 
calcium present in the constructs.   
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However, visual examination of the SEM micrographs in Figure 5.5 provides 
more information with lower amounts of ECM observed on the dM 12 constructs 
as compared to the EO 12, FT 12, and Tri 12 constructs and markedly lower 
amounts of ECM observed on the dM 16 constructs as compared to the EO 16, 
FT 16, and Tri 16 constructs.  Similarly, the histological sections reveal that there 
is a drastic loss in the thickness of the GAG, collagen, and calcium layers within 
the constructs after devitalization and demineralization.  The discrepancy 
between the quantitative and qualitative analysis may be a result of the 
methodology used to gather the images.   The SEM micrographs obtained can 
only demonstrate the amount of ECM coating present on the surface of the 
construct and does not provide the amount of ECM present within the interior of 
the constructs.  With regards to the histological images, the processing 
performed to create the FT, Tri, and dM constructs may have allowed for ECM 
loss to occur while generating fixed and embedded samples for sectioning. 
 
Further study of the histological images illustrates that there are differences seen 
in the thickness of the GAG layer for both PCL/ECM 12 and PCL/ECM 16 
constructs.  The EO constructs have a thicker layer of GAGs as compared to the 
FT constructs which in turn has a thicker layer of GAGs than either the Tri or dM 
constructs.  A similar loss in collagen thickness is observed in the picrosirius red 
staining of the FT, Tri, and dM constructs as compared to the EO constructs.  
Nevertheless, the FT constructs contain a thicker layer of collagen than either the 
Tri or dM constructs.  In each treatment, the processed constructs are either 
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exposed to water or ammonium hydroxide in order to cause cell lysis, but these 
neither destroy nor remove the GAGs or collagen from the ECM.199,212  However, 
exposure of the PCL/ECM constructs to freezing and thawing, ultrasonication, or 
continuous stirring can disrupt the ECM while Triton X-100 exposure has been 
shown to remove GAGs in addition to disrupting the ECM.199  This can explain 
the observation of a thinner layer of GAGs and collagen in the Tri construct as 
compared to the EO and FT constructs.  The loss of GAGs and collagen 
observed in the dM constructs as compared to the FT constructs may also be 
explained by the additional demineralization step.  The dM constructs underwent 
the same devitalization steps as the FT constructs, but they are also soaked in a 
2% EDTA solution which was continuously stirred for 2 hours.  The extra time the 
dM constructs were agitated could potentially disrupt the ECM to a greater 
extent, resulting in a thinner layer of GAGs and collagen. 
 
In a similar trend to the collagen distribution, the alizarin red staining of the FT, 
Tri, and dM constructs demonstrated that there was a thinner layer of calcium 
present as compared to the EO constructs, but the FT constructs contained a 
thicker layer of calcium than the Tri or dM constructs.  This may be explained by 
the initiation and preferential deposition of calcium minerals along the collagen 
fibers in bone formation.11,12   The devitalization and demineralization techniques 
removed some of the collagen fibers and thus the calcium minerals bound to the 
collagen fibers would also be removed.  The end result is a similar trend between 
the calcium staining and collagen staining. 
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The MSC culture on the constructs demonstrated that cellular proliferation was 
similar on all of the PCL/ECM 12 constructs, but the dM 16 constructs had a 
significantly higher number of cells as compared to the EO 16, FT 16, and Tri 16 
constructs.  Examining the SEM micrographs of each of the constructs seen in 
Figure 5.5, it can be observed that each of the PCL/ECM 12 constructs had void 
spaces allowing access to the interior of the construct.  However, between the 
PCL/ECM 16 constructs, the EO 16 constructs have minimal void space, the FT 
16 and Tri 16 constructs have some void space, while a large amount is 
observed in the dM 16 constructs.   
 
The void spaces observed within all of these cell-generated ECM constructs may 
potentially also be caused by the various devitalization and demineralization 
conditions.  Each of the treatments used within this study has been shown to 
disrupt the ECM.199  In the freeze-thaw devitalization method, numerous small ice 
crystals are created by the rapid freezing of water and thus leaving gaps where 
the cells were present and ice crystals had formed.213  With the detergent 
method, the lipids present in the cell membrane would be dissociated, creating 
spaces where cells once were.214   In the case of the demineralization procedure, 
some proteins and proteoglycans present within the ECM layer may have been 
solubilized or disrupted by the chelating agent, EDTA.215  In addition, the 
agitation caused by the magnetic stir bar during the demineralization procedure 
generates convective forces throughout the construct.216  Both EDTA and 
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agitation would cause some loss of ECM components from the constructs, thus 
leaving gaps in the surface ECM layer. 
 
With the presence of void spaces, the MSCs seeded onto the PCL/ECM 12 
constructs and dM 16 constructs may have been able to infiltrate into the interior 
and proliferate.  Indeed, this is supported by similar levels of cell number seen on 
dM 16 constructs at day 12 as compared to the PCL/ECM 12 constructs at day 
12.  Histological staining also supports this with the EO 12, FT 12, dM 12, and 
dM 16 constructs filling with ECM in the interior of the constructs. 
 
MSCs seeded onto Tri 12 constructs were also able to access the interior of the 
construct and generated an ECM layer at the top of the construct by day 8, but 
by day 12, the ECM coating had largely disappeared.  Potentially, there may be 
some remnants of Triton X-100 left within the constructs which could cause cell 
lysis.  Consequently, proteases may have been released which would have 
digested the ECM, resulting in a thin layer of ECM remaining by day 12.   
 
Meanwhile the histological staining of the EO 16 constructs demonstrate that the 
MSCs were having difficulty in accessing the interior of the construct and instead 
have generated a second layer of ECM above the first ECM coating.  However, 
the FT 16 constructs allowed some MSC access into the interior of the construct 
and had increases in ECM deposition at the top and bottom layers of the 
construct with minimal increase in matrix in the interior of the constructs.  
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Similarly, the Tri 16 constructs allowed MSCs access and had ECM present at 
the top layer of the construct at day 8, but the ECM deposited in the Tri 16 
constructs later disappeared by day 12, possibly due to the same reason as the 
Tri 12 constructs.   
 
The cell proliferation data also shows that the dM 12 constructs had a 
significantly lower number of cells present at day 8 when compared to the EO 12, 
FT 12, and Tri 12 constructs.  This may be a result of the dM 12 construct having 
lost a greater thickness of GAGs and collagen than the other PCL/ECM 12 
constructs.  With this loss of ECM components, the MSCs may have had 
difficulty proliferating until they deposited enough ECM within the construct. 
 
The ALP activity of the seeded MSCs demonstrates that there was no significant 
difference in activity between any of the PCL/ECM 12 constructs.  This suggests 
that the processing techniques didn’t remove any of the osteogenic components 
from the deposited ECM.  However, the EO 16 construct had a significantly 
higher ALP activity as compared to dM 16 and Tri 16 at day 8 and day 12, 
respectively.  In this case, the demineralization and detergent processing may 
have removed an osteogenic component present in the unprocessed constructs, 
since this effect isn’t seen in the FT 16 construct.  In fact, the FT 16 constructs 
demonstrated a significantly higher ALP activity at day 12 as compared to the EO 
16, Tri 16, and dM 16 constructs.  This may be due to the combination of higher 
amounts of ECM components as compared to the Tri 16 and dM 16 constructs in 
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conjunction with greater access to the interior of the construct as compared to 
the EO 16 constructs, which may have prolonged the osteogenic differentiation of 
the MSCs.  In addition, since the difference in ALP activity between the 
processed constructs is only seen in the PCL/ECM 16 constructs, there may be 
an important osteogenic component present in the PCL/ECM 16 not found in the 
PCL/ECM 12.  This is also supported by the significantly higher difference in ALP 
activity seen between the EO 12 and EO 16 constructs at day 4 and day 12 and 
the FT 12 and FT 16 constructs at day 12. 
 
The calcium data illustrates that there was no significant difference in the calcium 
deposition between the EO 12, FT 12, and Tri 12 constructs.  This may be 
explained by the similarity between their ECM coatings seen in the SEM 
micrographs and the histological images.  Indeed, the cell proliferation and ALP 
activity data demonstrates that there were no significant differences between the 
constructs.  However, there was a significant difference in calcium deposited for 
the dM 12 and dM 16 constructs at day 12 as compared to the EO 12 and EO 16 
constructs, respectively.  Nevertheless, this is not surprising, since these 
constructs started off with much less mineralization as compared to any of the 
other constructs. 
 
The significant difference observed between the calcium deposition in FT 16 and 
EO 16 constructs may be related to the ALP activity.  ALP activity is an early 
osteogenic differentiation marker and calcium deposition is a late stage marker.  
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Since the MSCs seeded onto FT 16 constructs demonstrated a significantly 
higher ALP activity than MSCs seeded onto EO 16 constructs, the MSCs may 
have not differentiated into osteoblasts by day 12.   
 
Interestingly, there were no significant differences in calcium amounts between 
the PCL/ECM 12 constructs and their respective PCL/ECM 16 constructs.  This 
may suggest that both the 12 day and 16 day ECM coatings are equally 
osteogenic.  However, on the other hand, it may be a result of minimal amounts 
of ECM present in the PCL/ECM 12 constructs and the lack of access into the 
interior of the construct for the PCL/ECM 16 constructs. 
 
5.5 Conclusions 
This study explored the effect of various devitalization and demineralization 
techniques on the retention of ECM components within cell-generated ECM 
constructs and the osteogenic differentiation of MSCs seeded onto these 
constructs.  Of all the processing techniques examined, histological analysis 
demonstrated that the freeze-thaw method contained the thickest layer of GAGs, 
collagen, and calcium within the constructs.  In addition, the culture of MSCs on 
freeze-thaw treated PCL/ECM 16 constructs affected their osteogenic 
differentiation, with a significantly higher ALP activity and minimal amounts of 
calcium deposition at late stage culture as compared to untreated PCL/ECM 16 
constructs.  Moreover, each of the devitalization and demineralization techniques 
generated void spaces in surface of the ECM coating due to cell lysis, ice crystal 
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formation, and loss of ECM components.  The presence of these void spaces 
enhanced cell infiltration and proliferation within the constructs.  Overall, this 
study establishes that the freeze-thaw technique is the least harsh method of 
devitalization of cell-generated ECM constructs and additionally generates void 
spaces in the ECM coating allowing access of MSCs into the interior of the 
constructs. 
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Processing 
Type 
Technique Initial 
Construct 
Resulting 
Construct 
Sterilization Only 1.  Exposure to ethylene oxide 
     for 14 hours 
PCL/ECM 12 EO 12 
PCL/ECM 16 EO 16 
 
 
 
Freeze-Thaw 
Devitalization 
1.  Place in 1 mL of Millipore 
     filtered water 
2.  3 cycles of freezing at -196oC 
     followed by thawing at 37oC 
3.  10 minutes of ultrasonication 
4.  2 rinses with Millipore 
     filtered water 
5.  Air dry 
6.  Exposure to ethylene oxide 
     for 14 hours 
 
 
PCL/ECM 12 
 
 
FT 12 
 
 
PCL/ECM 16 
 
 
FT 16 
 
 
 
Detergent 
Devitalization 
1.  Place in 1 mL of 0.5% v/v 
     Triton-X 100 and 0.05% v/v 
     NH4OH 
2.  Shake at 100 rpm for 1 hour 
     at room temperature 
3.  3 rinses with Millipore 
     filtered water 
4.  Air dry 
5.  Exposure to ethylene oxide 
     for 14 hours 
 
PCL/ECM 12 
 
Tri 12 
 
 
PCL/ECM 16 
 
 
Tri 16 
 
 
 
Demineralization 
and Devitalization 
1.  Place in 1 mL of Millipore 
     filtered water 
2.  3 cycles of freezing at -196oC 
     followed by thawing at 37oC 
3.  10 minutes of ultrasonication 
4.  Place in 40 mL of 2% w/v 
     ethylenediaminetetraacetic 
     acid (EDTA) 
5.  Stir at 72 rpm for 2 hours 
6.  2 rinses with Millipore 
     filtered water 
7.  Exposure to ethylene oxide 
     for 14 hours 
 
 
PCL/ECM 12 
 
 
dM 12 
 
 
PCL/ECM 16 
 
 
dM 16 
 
Table 5.1:  The processing methods and the techniques used to generate 
devitalized and demineralized constructs. 
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Figure 5.1:  DNA content within each of the different processed constructs prior 
to being reseeded with MSCs.  Groups not connected by the same letter 
indicates significant difference (p<0.05).  Data are expressed as means ± 
standard deviation for n=3. 
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Figure 5.2:  Glycoasminoglycan content within each of the different processed 
constructs prior to being reseeded with MSCs.  Groups not connected by the 
same letter indicates significant difference (p<0.05).  Data are expressed as 
means ± standard deviation for n=3. 
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Figure 5.3:  Collagen content within each of the different processed constructs 
prior to being reseeded with MSCs.  Groups not connected by the same letter 
indicates significant difference (p<0.05).  Data are expressed as means ± 
standard deviation for n=3. 
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Figure 5.4:  Calcium content within each of the different processed constructs 
prior to being reseeded with MSCs.  Groups not connected by the same letter 
indicates significant difference (p<0.05).  Data are expressed as means ± 
standard deviation for n=3. 
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Figure 5.5:  Scanning electron micrograph of the processed constructs at a 250X 
magnification. Each micrograph demonstrates the void spaces generated in the 
ECM coating by the devitalization and demineralization techniques.  A) EO 12, B) 
FT 12, C) Tri 12, D) dM 12, E) EO 16, F) FT 16, G) Tri 16, H) dM 16. 
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Figure 5.6i:  Histological images of the processed constructs at 5X 
magnification.  Constructs were cut into 5 µm sections and stained with Safranin 
O.A) EO 12, B) FT 12, C) Tri 12, D) dM 12, E) EO 16, F) FT 16, G) Tri 16, H) dM 
16. 
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Figure 5.6ii:  Histological images of the processed constructs at 5X 
magnification.  Constructs were cut into 5 µm sections and stained with 
Picrosirius Red.  A) EO 12, B) FT 12, C) Tri 12, D) dM 12, E) EO 16, F) FT 16, G) 
Tri 16, H) dM 16. 
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Figure 5.6iii:  Histological images of the processed constructs at 5X 
magnification.  Constructs were cut into 5 µm sections and stained with Alizarin 
Red.  A) EO 12, B) FT 12, C) Tri 12, D) dM 12, E) EO 16, F) FT 16, G) Tri 16, H) 
dM 16. 
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Figure 5.7:  Cellularity of the reseeded constructs at day 4, day 8, and day 12.  
Groups not connected by the same letter indicates significant difference (p<0.05).  
Data are expressed as means ± standard deviation for n=3. 
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Figure 5.8:  Alkaline phosphatase activity of the reseeded constructs at day 4, 
day 8, and day 12.  Groups not connected by the same letter indicates significant 
difference (p<0.05).  Data are expressed as means ± standard deviation for n=3. 
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Figure 5.9:  Calcium amounts present on each reseeded constructs at day 4, 
day 8, and day 12.  Groups not connected by the same letter indicates significant 
difference (p<0.05).  Data are expressed as means ± standard deviation for n=3. 
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Figure 5.10:  Scanning electron micrograph of the reseeded processed 
constructs at day 12 at a 250X magnification. Each micrograph demonstrates the 
coating of ECM produced by the reseeded MSCs.  A) EO 12, B) FT 12, C) Tri 12, 
D) dM 12, E) EO 16, F) FT 16, G) Tri 16, H) dM 16. 
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Figure 5.11i:  Histological images of the reseeded processed constructs at 5X 
magnification for the day 4, day 8, and day 12 timepoints.  Constructs were cut 
into 5 µm sections and stained with H & E.  A) EO 12 day 4, B) EO 12 day 8, C) 
EO 12 day 12, D) EO 16 day 4, E) EO 16 day 8, F) EO 16 day 12. 
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Figure 5.11ii:  Histological images of the reseeded processed constructs at 5X 
magnification for the day 4, day 8, and day 12 timepoints.  Constructs were cut 
into 5 µm sections and stained with H & E.  A) FT 12 day 4, B) FT 12 day 8, C) 
FT 12 day 12, D) FT 16 day 4, E) FT 16 day 8, F) FT 16 day 12. 
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Figure 5.11iii:  Histological images of the reseeded processed constructs at 5X 
magnification for the day 4, day 8, and day 12 timepoints.  Constructs were cut 
into 5 µm sections and stained with H & E.  A) Tri 12 day 4, B) Tri 12 day 8, C) 
Tri 12 day 12, D) Tri 16 day 4, E) Tri 16 day 8, F) Tri 16 day 12. 
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Figure 5.11iv:  Histological images of the reseeded processed constructs at 5X 
magnification for the day 4, day 8, and day 12 timepoints.  Constructs were cut 
into 5 µm sections and stained with H & E.  A) dM 12 day 4, B) dM 12 day 8, C) 
dM 12 day 12, D) dM 16 day 4, E) dM 16 day 8, F) dM 16 day 12. 
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CHAPTER 6 
 
Conclusions and Future Work 
 
The overall goal of this research work was to develop a MSC-generated ECM 
and PCL construct, determine its osteogenicity, and identify the components in 
the ECM that encourage the osteogenic differentiation of MSCs seeded onto the 
construct.  The specific aims outlined in the thesis overview allowed for 
confirmation of the osteogenicity of the PCL/ECM constructs and identification of 
the ECM components that were present within the osteogenic construct. 
 
Chapter 3 demonstrated that the statically cultured acellular PCL/ECM constructs 
contained a component that is conducive to calcium deposition and may 
mineralize over time in vivo without cells.  It was also shown that the in vitro cell-
generated ECM can sustain the osteogenic differentiation of MSCs even with the 
lack of the osteogenic supplement, dexamethasone.  In addition, it was 
demonstrated that the cell-generated ECM enhanced the proliferation of either 
MSCs or another cell population (or populations) present within the whole bone 
marrow. 
 
Given the information from the study presented in Chapter 3, it was logical to 
explore the changes in protein and mineral composition of the osteogenic 
PCL/ECM constructs over time.  Chapter 4 showed that at early ECM maturities, 
it was composed of cellular adhesion proteins, such as fibronectin.  Meanwhile, 
at later stages of ECM maturities, it was mainly composed of matrix remodeling 
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and regulatory proteins, such as MMP-2 and PEDF.  The constructs were also 
found to contain the major components of mature bone, collagen 1 and 
hydroxyapatite along with fibril-regulating proteins that help to organize both 
collagen 1 and fibronectin, thus demonstrating that the ECM has started to 
resemble mature bone.   
 
The PCL/ECM constructs studied previously have all undergone a freeze-thaw 
devitalization procedure.  Chapter 5 explored the effect of various devitalization 
and demineralization processes on the retention of major ECM components and 
the osteogenicity of the treated constructs.  The freeze-thaw devitalization 
method was shown to disrupt the ECM the least, retaining a thicker layer of 
GAGs, collagen, and calcium within the constructs as compared to the other 
processing methods.  In addition, this study demonstrates that void spaces in the 
surface of the ECM coating on the constructs are important for allowing access of 
MSCs into the interior of the constructs enhancing matrix production within the 
constructs. 
 
The result of the research described in this thesis reveals that osteogenically pre-
differentiated MSC-generated PCL/ECM constructs are osteogenic and contain 
some of the components of mature bone.  Furthermore, devitalizing the 
constructs using a minimally disruptive process, such as freeze-thaw cycles 
enhances MSC access to the interior of the construct as compared to untreated 
constructs.   
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Of further interest would be the exploration of the creation of the ECM coating on 
well-characterized and pre-designed scaffolds.  Electrospun scaffolds are well-
characterized, but it is difficult to create clinically relevant shapes using only 
electrospinning.  3D printing allows for the generation of scaffolds that are able to 
be formed into irregular shapes but with known pore sizes.  Future studies can 
investigate whether drastically different pore sizes affects the composition of the 
ECM deposited by the cells.   
 
Additional future studies investigating the performance of the PCL/ECM 
constructs in an in vivo environment, whether it be at an ectopic or orthotopic site 
would provide insight into the inflammatory nature of the construct as well as the 
integration of the construct to the surrounding bone of a defect and the extent of 
bone formation within the entirety of the construct.  These investigations would 
provide more conclusive evidence of the osteogenicity of the constructs and 
validate the results observed within this thesis. 
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